Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-Q
 
(Mark One)
 	 	 	
þ	 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
For the quarterly period ended June 30, 2011
Or
 	 	 	
o	 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
For the transition period from                      to                     
Commission file number: 001-31719
 
Molina Healthcare, Inc.
(Exact name of registrant as specified in its charter)
 	 	 	
Delaware
(State or other jurisdiction of
incorporation or organization)	 	13-4204626
(I.R.S. Employer
Identification No.)	
 	 	 	
200 Oceangate, Suite 100	 	 	
Long Beach, California	 	90802	
(Address of principal executive offices)	 	(Zip Code)	
(562) 435-3666
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  þ  No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 	 	 	 	 	 	 	
Large accelerated filer o	 	Accelerated filer þ	 	Non-accelerated filer o	 	Smaller reporting company o	
 	 	 	 	(Do not check if a smaller reporting company)	 	 	
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o  No  þ
The number of shares of the issuer’s Common Stock outstanding as of July 21, 2011, was approximately 46,065,000.

 

 
MOLINA HEALTHCARE, INC.
Index
 	 	 	 	 	 	 	 	 	
Part I — Financial Information

Item 1. Financial Statements	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Consolidated Balance Sheets as of June 30, 2011 (unaudited) and December 31, 2010	 	 	1	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Consolidated Statements of Income for the three month and six month periods ended June 30, 2011 and 2010 (unaudited)	 	 	2	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Consolidated Statements of Comprehensive Income for the three month and six month periods ended June 30, 2011 and 2010 (unaudited)	 	 	3	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Consolidated Statements of Cash Flows for the six months ended June 30, 2011 and 2010 (unaudited)	 	 	4	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Notes to Consolidated Financial Statements (unaudited)	 	 	6	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	 	 	22	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 3. Quantitative and Qualitative Disclosures About Market Risk	 	 	48	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 4. Controls and Procedures	 	 	48	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Part II — Other Information

Item 1. Legal Proceedings	 	 	49	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 1A. Risk Factors	 	 	49	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 6. Exhibits	 	 	49	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Signatures	 	 	50	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
 Exhibit 31.1	
 Exhibit 31.2	
 Exhibit 32.1	
 Exhibit 32.2	
 EX-101 INSTANCE DOCUMENT	
 EX-101 SCHEMA DOCUMENT	
 EX-101 CALCULATION LINKBASE DOCUMENT	
 EX-101 LABELS LINKBASE DOCUMENT	
 EX-101 PRESENTATION LINKBASE DOCUMENT	

 

Table of Contents
PART I — FINANCIAL INFORMATION
 	 	 	
Item 1.	 	Financial Statements.	
MOLINA HEALTHCARE, INC.
CONSOLIDATED BALANCE SHEETS
 	 	 	 	 	 	 	 	 	
 	 	June 30,	 	 	December 31,	 	
 	 	2011	 	 	2010	 	
 	 	(Amounts in thousands,	 	
 	 	except per-share data)	 	
 	 	(Unaudited)	 	 	 	 	 	
ASSETS
	
Current assets:	 	 	 	 	 	 	 	 	
Cash and cash equivalents	 	$	459,213	 	 	$	455,886	 	
Investments	 	 	356,600	 	 	 	295,375	 	
Receivables	 	 	172,674	 	 	 	168,190	 	
Deferred income taxes	 	 	16,423	 	 	 	15,716	 	
Prepaid expenses and other current assets	 	 	23,246	 	 	 	22,772	 	
 	 	 	 	 	 	 	
Total current assets	 	 	1,028,156	 	 	 	957,939	 	
Property and equipment, net	 	 	117,836	 	 	 	100,537	 	
Deferred contract costs	 	 	42,557	 	 	 	28,444	 	
Intangible assets, net	 	 	91,237	 	 	 	105,500	 	
Goodwill and indefinite-lived intangible assets	 	 	212,484	 	 	 	212,228	 	
Auction rate securities	 	 	18,958	 	 	 	20,449	 	
Restricted investments	 	 	50,330	 	 	 	42,100	 	
Receivable for ceded life and annuity contracts	 	 	24,075	 	 	 	24,649	 	
Other assets	 	 	14,788	 	 	 	17,368	 	
 	 	 	 	 	 	 	
 	 	$	1,600,421	 	 	$	1,509,214	 	

LIABILITIES AND STOCKHOLDERS’ EQUITY
	
Current liabilities:	 	 	 	 	 	 	 	 	
Medical claims and benefits payable	 	$	341,613	 	 	$	354,356	 	
Accounts payable and accrued liabilities	 	 	133,005	 	 	 	137,930	 	
Deferred revenue	 	 	128,599	 	 	 	60,086	 	
Income taxes payable	 	 	5,605	 	 	 	13,176	 	
 	 	 	 	 	 	 	
Total current liabilities	 	 	608,822	 	 	 	565,548	 	
Long-term debt	 	 	166,725	 	 	 	164,014	 	
Deferred income taxes	 	 	14,468	 	 	 	16,235	 	
Liability for ceded life and annuity contracts	 	 	24,075	 	 	 	24,649	 	
Other long-term liabilities	 	 	20,474	 	 	 	19,711	 	
 	 	 	 	 	 	 	
Total liabilities	 	 	834,564	 	 	 	790,157	 	
 	 	 	 	 	 	 	
Stockholders’ equity (1):	 	 	 	 	 	 	 	 	
Common stock, $0.001 par value; 80,000 shares authorized; outstanding: 46,062 shares at June 30, 2011 and 45,463 shares at December 31, 2010	 	 	46	 	 	 	45	 	
Preferred stock, $0.001 par value; 20,000 shares authorized, no shares issued and outstanding	 	 	—	 	 	 	—	 	
Additional paid-in capital	 	 	262,988	 	 	 	251,612	 	
Accumulated other comprehensive loss	 	 	(1,597	)	 	 	(2,192	)	
Retained earnings	 	 	504,420	 	 	 	469,592	 	
 	 	 	 	 	 	 	
Total stockholders’ equity	 	 	765,857	 	 	 	719,057	 	
 	 	 	 	 	 	 	
 	 	$	1,600,421	 	 	$	1,509,214	 	

(1)	 	All applicable share and per-share amounts reflect the retroactive effects of the three-for-two common stock split in the form of a stock dividend that was effective May 20, 2011.	
See accompanying notes.

1

Table of Contents
MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF INCOME
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	 	Six Months Ended	 	
 	 	June 30,	 	 	June 30,	 	
 	 	2011	 	 	2010	 	 	2011	 	 	2010	 	
 	 	(Amounts in thousands, except	 	
 	 	net income per share)	 	
 	 	(Unaudited)	 	
Revenue:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Premium revenue	 	$	1,128,770	 	 	$	976,685	 	 	$	2,210,208	 	 	$	1,941,905	 	
Service revenue	 	 	36,888	 	 	 	21,054	 	 	 	73,562	 	 	 	21,054	 	
Investment income	 	 	1,446	 	 	 	1,599	 	 	 	3,040	 	 	 	3,120	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total revenue	 	 	1,167,104	 	 	 	999,338	 	 	 	2,286,810	 	 	 	1,966,079	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Expenses:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Medical care costs	 	 	949,359	 	 	 	839,613	 	 	 	1,862,891	 	 	 	1,662,429	 	
Cost of service revenue	 	 	39,215	 	 	 	14,254	 	 	 	70,436	 	 	 	14,254	 	
General and administrative expenses	 	 	96,921	 	 	 	78,079	 	 	 	191,357	 	 	 	156,959	 	
Premium tax expenses	 	 	37,709	 	 	 	34,995	 	 	 	74,259	 	 	 	69,541	 	
Depreciation and amortization	 	 	12,490	 	 	 	11,219	 	 	 	25,157	 	 	 	21,280	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total expenses	 	 	1,135,694	 	 	 	978,160	 	 	 	2,224,100	 	 	 	1,924,463	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Operating income	 	 	31,410	 	 	 	21,178	 	 	 	62,710	 	 	 	41,616	 	
Interest expense	 	 	3,683	 	 	 	4,099	 	 	 	7,286	 	 	 	7,456	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Income before income taxes	 	 	27,727	 	 	 	17,079	 	 	 	55,424	 	 	 	34,160	 	
Provision for income taxes	 	 	10,287	 	 	 	6,500	 	 	 	20,596	 	 	 	12,991	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income	 	$	17,440	 	 	$	10,579	 	 	$	34,828	 	 	$	21,169	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income per share (1):	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Basic	 	$	0.38	 	 	$	0.27	 	 	$	0.76	 	 	$	0.55	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Diluted	 	$	0.38	 	 	$	0.27	 	 	$	0.75	 	 	$	0.54	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Weighted average shares outstanding (1):	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Basic	 	 	45,897	 	 	 	38,611	 	 	 	45,743	 	 	 	38,541	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Diluted	 	 	46,471	 	 	 	38,926	 	 	 	46,392	 	 	 	38,929	 	

(1)	 	All applicable share and per-share amounts reflect the retroactive effects of the three-for-two common stock split in the form of a stock dividend that was effective May 20, 2011.	
See accompanying notes.

2

Table of Contents
MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	 	Six Months Ended	 	
 	 	June 30,	 	 	June 30,	 	
 	 	2011	 	 	2010	 	 	2011	 	 	2010	 	
 	 	(Amounts in thousands)	 	
 	 	(Unaudited)	 	
Net income	 	$	17,440	 	 	$	10,579	 	 	$	34,828	 	 	$	21,169	 	
Other comprehensive income, net of tax:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Unrealized gain (loss) on investments	 	 	712	 	 	 	(355	)	 	 	595	 	 	 	(227	)	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Other comprehensive income (loss)	 	 	712	 	 	 	(355	)	 	 	595	 	 	 	(227	)	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Comprehensive income	 	$	18,152	 	 	$	10,224	 	 	$	35,423	 	 	$	20,942	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
See accompanying notes.

3

Table of Contents
MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
 	 	 	 	 	 	 	 	 	
 	 	Six Months Ended	 	
 	 	June 30,	 	
 	 	2011	 	 	2010	 	
 	 	(Amounts in thousands)	 	
 	 	(Unaudited)	 	
Operating activities:	 	 	 	 	 	 	 	 	
Net income	 	$	34,828	 	 	$	21,169	 	
Adjustments to reconcile net income to net cash provided by operating activities:	 	 	 	 	 	 	 	 	
Depreciation and amortization	 	 	34,602	 	 	 	23,912	 	
Deferred income taxes	 	 	(2,839	)	 	 	624	 	
Stock-based compensation	 	 	8,374	 	 	 	4,508	 	
Non-cash interest on convertible senior notes	 	 	2,711	 	 	 	2,509	 	
Amortization of premium/discount on investments	 	 	3,439	 	 	 	560	 	
Amortization of deferred financing costs	 	 	1,007	 	 	 	687	 	
Unrealized gain on trading securities	 	 	—	 	 	 	(2,860	)	
Loss on rights agreement	 	 	—	 	 	 	2,611	 	
Tax deficiency from employee stock compensation	 	 	(489	)	 	 	(383	)	
Changes in operating assets and liabilities:	 	 	 	 	 	 	 	 	
Receivables	 	 	(4,424	)	 	 	(1,598	)	
Prepaid expenses and other current assets	 	 	(2,780	)	 	 	(6,348	)	
Medical claims and benefits payable	 	 	(12,743	)	 	 	30,284	 	
Accounts payable and accrued liabilities	 	 	(8,715	)	 	 	27,958	 	
Deferred revenue	 	 	69,498	 	 	 	(82,680	)	
Income taxes	 	 	(7,571	)	 	 	4,910	 	
 	 	 	 	 	 	 	
Net cash provided by operating activities	 	 	114,898	 	 	 	25,863	 	
 	 	 	 	 	 	 	
Investing activities:	 	 	 	 	 	 	 	 	
Purchases of equipment	 	 	(30,866	)	 	 	(17,523	)	
Purchases of investments	 	 	(183,647	)	 	 	(91,768	)	
Sales and maturities of investments	 	 	121,434	 	 	 	116,276	 	
Net cash paid in business combinations	 	 	(3,253	)	 	 	(134,400	)	
Increase in deferred contract costs	 	 	(16,405	)	 	 	(8,018	)	
Increase in restricted investments	 	 	(8,230	)	 	 	(4,754	)	
Change in other noncurrent assets and liabilities	 	 	2,190	 	 	 	757	 	
 	 	 	 	 	 	 	
Net cash used in investing activities	 	 	(118,777	)	 	 	(139,430	)	
 	 	 	 	 	 	 	
Financing activities:	 	 	 	 	 	 	 	 	
Amount borrowed under credit facility	 	 	—	 	 	 	105,000	 	
Credit facility fees paid	 	 	—	 	 	 	(1,671	)	
Proceeds from employee stock plans	 	 	5,640	 	 	 	1,543	 	
Excess tax benefits from employee stock compensation	 	 	1,566	 	 	 	179	 	
 	 	 	 	 	 	 	
Net cash provided by financing activities	 	 	7,206	 	 	 	105,051	 	
 	 	 	 	 	 	 	
Net increase (decrease) in cash and cash equivalents	 	 	3,327	 	 	 	(8,516	)	
Cash and cash equivalents at beginning of period	 	 	455,886	 	 	 	469,501	 	
 	 	 	 	 	 	 	
Cash and cash equivalents at end of period	 	$	459,213	 	 	$	460,985	 	
 	 	 	 	 	 	 	
See accompanying notes.

4

Table of Contents
MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS — (continued)
 	 	 	 	 	 	 	 	 	
 	 	Six Months Ended	 	
 	 	June 30,	 	
 	 	2011	 	 	2010	 	
 	 	(Amounts in thousands)	 	
 	 	(Unaudited)	 	
Supplemental cash flow information:	 	 	 	 	 	 	 	 	
Cash paid during the period for:	 	 	 	 	 	 	 	 	
Income taxes	 	$	30,863	 	 	$	6,604	 	
 	 	 	 	 	 	 	
Interest	 	$	4,385	 	 	$	6,222	 	
 	 	 	 	 	 	 	
Schedule of non-cash investing and financing activities:	 	 	 	 	 	 	 	 	
Retirement of common stock used for stock-based compensation	 	$	3,714	 	 	$	1,673	 	
 	 	 	 	 	 	 	
Details of business combinations:	 	 	 	 	 	 	 	 	
Increase in fair value of assets acquired	 	$	(256	)	 	$	(143,983	)	
(Decrease) increase in fair value of liabilities assumed	 	 	(1,045	)	 	 	11,832	 	
Decrease in payable to seller	 	 	(1,952	)	 	 	(2,249	)	
 	 	 	 	 	 	 	
Net cash paid in business combinations	 	$	(3,253	)	 	$	(134,400	)	
 	 	 	 	 	 	 	
See accompanying notes.

5

Table of Contents
MOLINA HEALTHCARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
June 30, 2011
1. Basis of Presentation
Organization and Operations
Molina Healthcare, Inc. provides quality and cost-effective Medicaid-related solutions to meet the health care needs of low-income families and individuals and to assist state agencies in their administration of the Medicaid program.
Our Health Plans segment comprises health plans in California, Florida, Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin. As of June 30, 2011, these health plans served approximately 1.6 million members eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals. The health plans are operated by our respective wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization, or HMO.
Our Molina Medicaid Solutions segment, which we acquired during the second quarter of 2010, provides business processing and information technology development and administrative services to Medicaid agencies in Idaho, Louisiana, Maine, New Jersey, and West Virginia, and drug rebate administration services in Florida.
On June 9, 2011, Molina Medicaid Solutions received notice from the state of Louisiana that the state intends to award the contract for a replacement Medicaid Management Information System, or MMIS, to another firm. We have submitted a protest in connection with this notice, and in response the state has issued a stay of the intent to award and all contract negotiations have ceased. Our revenue under the Louisiana MMIS contract from May 1, 2010, the date we acquired Molina Medicaid Solutions, through December 31, 2010, was approximately $32 million. For the six months ended June 30, 2011, our revenue under the Louisiana MMIS contract was approximately $24 million. Until the replacement MMIS is designed, developed, and implemented by the vendor that ultimately enters into a contract with the state, we will continue to perform under the existing MMIS contract, a period which we expect to last at least two years.
Consolidation and Interim Financial Information
The consolidated financial statements include the accounts of Molina Healthcare, Inc. and all majority owned subsidiaries. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the interim periods presented have been included; such adjustments consist of normal recurring adjustments. All significant intercompany balances and transactions have been eliminated in consolidation. The consolidated results of operations for the current interim period are not necessarily indicative of the results for the entire year ending December 31, 2011. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition.
The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to our audited consolidated financial statements for the fiscal year ended December 31, 2010. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in the December 31, 2010 audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with our December 31, 2010 audited financial statements.
Adjustments and Reclassifications
We have adjusted all applicable share and per-share amounts to reflect the retroactive effects of the three-for-two stock split in the form of a stock dividend that was effective May 20, 2011.

6

Table of Contents
We have reclassified certain amounts in the 2010 consolidated statement of cash flows to conform to the 2011 presentation.
2. Significant Accounting Policies
Recognition of Service Revenue and Cost of Service Revenue — Molina Medicaid Solutions Segment
The payments received by our Molina Medicaid Solutions segment under its state contracts are based on the performance of three elements of service. The first of these is the design, development and implementation, or DDI, of a Medicaid Management Information System, or MMIS. The second element, following completion of the DDI element, is the operation of the MMIS under a business process outsourcing, or BPO, arrangement. While providing BPO services, we also provide the state with the third contracted element — training and IT support and hosting services (training and support).
Because they include these three elements of service, our Molina Medicaid Solutions contracts are multiple-element arrangements. The following discussion applies to our contracts with multiple elements entered into prior to January 1, 2011, before our prospective adoption of  Accounting Standards Update, or ASU, No. 2009-13, Revenue Recognition (Accounting Standards Codification, or ASC, Topic 605) — Multiple-Deliverable Revenue Arrangements .
For those contracts entered into prior to January 1, 2011, we have no vendor specific objective evidence, or VSOE, of fair value for any of the individual elements in these contracts, and at no point in the contract will we have VSOE for the undelivered elements in the contract. We lack VSOE of the fair value of the individual elements of our Molina Medicaid Solutions contracts for the following reasons:
 	•	 	Each contract calls for the provision of its own specific set of products and services, which vary significantly between contracts; and	

 	•	 	The nature of the MMIS installed varies significantly between our older contracts (proprietary mainframe systems) and our newer contracts (commercial off-the-shelf technology solutions).	
The absence of VSOE within the context of a multiple element arrangement requires us to delay recognition of any revenue for an MMIS contract until completion of the DDI phase of the contract. As a general principle, revenue recognition will therefore commence at the completion of the DDI phase, and all revenue will be recognized over the period that BPO services and training and support services are provided. Consistent with the deferral of revenue, recognition of all direct costs (such as direct labor, hardware, and software) associated with the DDI phase of our contracts is deferred until the commencement of revenue recognition. Deferred costs are recognized on a straight-line basis over the period of revenue recognition.
Provisions specific to each contract may, however, lead us to modify this general principle. In those circumstances, the right of the state to refuse acceptance of services, as well as the related obligation to compensate us, may require us to delay recognition of all or part of our revenue until that contingency (the right of the state to refuse acceptance) has been removed. In those circumstances we defer recognition of any revenue at risk (whether DDI, BPO services, or training and support services) until the contingency has been removed. When we defer revenue recognition we also defer recognition of incremental direct costs (such as direct labor, hardware, and software) associated with the revenue deferred. Such deferred contract costs are recognized on a straight-line basis over the period of revenue recognition.
However, direct costs in excess of the estimated future net revenues associated with a contract may not be deferred. In circumstances where estimated direct costs over the life of a contract exceed estimated future net revenues of that contract, the excess of direct costs over revenue is expensed as a period cost. As noted below, we were unable to defer $7.0 million of direct contract costs associated with our Idaho contract during the second quarter of 2011 because estimated direct costs over the life of the contract exceed estimated future net revenues.
We began to recognize revenue and the related deferred costs associated with our Maine contract in September 2010.

7

Table of Contents
In Idaho, revenue recognition is expected to begin during the second half of 2012. Consistent with the deferral of revenue, we have deferred recognition of the direct contract costs associated with that revenue. Deferred contract costs, if any, deferred through the date revenue recognition begins will be recognized simultaneously with revenue.
In late April of 2011, Idaho Department of Health and Welfare indicated that it wished to remit to us an amount approximately $5 to $6 million less than the amount of our invoices for the operation of the MMIS in that state for the period June 1, 2010 through December 31, 2010. The Department claimed at that time that we were not in compliance with certain contractual requirements during the period June 1, 2010 through December 31, 2010. We do not believe the basis of the proposed reduction was contractually sound. In June 2011, we reached tentative agreement with the Department regarding the determination of our monthly operating revenue in Idaho. As a result of the tentative agreement, we estimate that revenue from operations in Idaho will be reduced by approximately $3 million for the period June 1, 2010 through June 30, 2011, and by an additional $1 million for the period July 1, 2011 through December 31, 2011. We do not believe that the tentative agreement will result in any reduction to amounts previously expected to be received for operations subsequent to December 31, 2011. As noted above, all revenue associated with our Idaho MMIS contract is currently being deferred.
In assessing the recoverability of the deferred contract costs associated with the Idaho contract at June 30, 2011, we determined that our current estimate of expenses over the life of the Idaho MMIS contract exceeded our current estimate of net revenues to be derived from that contract by approximately $7.0 million. Accordingly, we expensed through cost of service revenue $7.0 million of direct costs associated with the Idaho contract that otherwise would have been recorded as deferred contract costs. The reduction in revenue discussed above, as well as higher expected costs over the term of the contract, have lowered the net amount that we expect to realize under the contract, requiring us to write down deferred contract costs. We currently expect the contract to perform financially at a break-even basis through its initial term. So long as we continue to defer revenue recognition under the contract, we will also continue to defer direct costs associated with the agreement, unless our analysis indicates that the contract is performing at less than break even.
Molina Medicaid Solutions’ deferred revenue totalled $38.6 million at June 30, 2011, and $10.9 million at December 31, 2010, and unamortized deferred contract costs were $42.6 million at June 30, 2011, and $28.4 million at December 31, 2010.
For all new or materially modified revenue arrangements with multiple elements entered into on or after January 1, 2011, which we expect will consist of contracts entered into by our Molina Medicaid Solutions segment, we apply the guidance contained in ASU No. 2009-13. For these arrangements, we allocate total arrangement consideration to the elements of the arrangement, which are expected to be DDI, BPO, and training and support, because this is consistent with the current elements included in our Molina Medicaid Solutions contracts. The arrangement allocation is performed using the relative selling-price method. When determining the selling price of each element, we first attempt to use VSOE if available. If VSOE is not available, we attempt to use third-party evidence, or TPE, of vendors selling similar services to similarly situated customers on a standalone basis, if available. If neither VSOE nor TPE are available, we use our best estimate of the selling price for each element.
We then evaluate whether, at each stage in the life cycle of the contract, we are able to recognize revenue associated with that element. To the extent that our revenue arrangements have provisions that allow our state customers to refuse acceptance of services performed, we are still required to defer revenue recognition until such state customers accept our performance. Once this acceptance is achieved, we immediately recognize the revenue associated with any delivered elements which differs from our current practice for arrangements entered into prior to January 1, 2011, where the revenue associated with delivered elements is recognized over the final service element of the arrangement because VSOE for the other elements does not exist. As such, we expect that the adoption of ASU No. 2009-13 will result in an overall acceleration of revenue recognition with respect to any multiple-element arrangements entered into on or after January 1, 2011. We have entered into no new or materially modified revenue arrangements with multiple elements since January 1, 2011.

8

Table of Contents
Premium Deficiency Reserve
We assess the profitability of each contract by state for providing medical care services to our members and identify any contracts where current operating results or forecasts indicate probable future losses. Anticipated future premiums are compared to anticipated medical care costs, including the cost of processing claims. If the anticipated future costs exceed the premiums, a loss contract accrual is recognized. In the first quarter of 2011, our Wisconsin health plan recorded a premium deficiency reserve in the amount of $3.35 million to medical claims and benefits payable. As of June 30, 2011, the reserve balance was $1.6 million.
Income Taxes
The provision for income taxes is determined using an estimated annual effective tax rate, which is generally greater than the U.S. federal statutory rate primarily because of state taxes. The effective tax rate may be subject to fluctuations during the year as new information is obtained. Such information may affect the assumptions used to estimate the annual effective tax rate, including factors such as the mix of pretax earnings in the various tax jurisdictions in which we operate, valuation allowances against deferred tax assets, the recognition or derecognition of tax benefits related to uncertain tax positions, and changes in or the interpretation of tax laws in jurisdictions where we conduct business. We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities, along with net operating loss and tax credit carryovers.
The total amount of unrecognized tax benefits was $11.0 million as of June 30, 2011 and December 31, 2010. Approximately $8.4 million of the unrecognized tax benefits recorded at June 30, 2011, relate to a tax position claimed on a state refund claim that will not result in a cash payment for income taxes if our claim is denied. The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate was $7.8 million as of June 30, 2011. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities may decrease by as much as $8.9 million due to the expiration of statute of limitations and the resolution to the state refund claim described above.
Our continuing practice is to recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. As of June 30, 2011, and December 31, 2010, we had accrued $95,000 and $82,000, respectively, for the payment of interest and penalties.
Recent Accounting Pronouncements
Revenue Recognition. In late 2009, the Financial Accounting Standards Board, or FASB, issued the following accounting guidance relating to revenue recognition. Effective for interim and annual reporting beginning on or after December 15, 2010, we adopted this guidance in full effective January 1, 2011.
 	•	 	ASU No. 2009-13, Revenue Recognition (ASC Topic 605) — Multiple-Deliverable Revenue Arrangements , a consensus of the FASB Emerging Issues Task Force. This guidance modifies previous requirements by requiring the use of the “best estimate of selling price” in the absence of vendor-specific objective evidence (“VSOE”) or verifiable objective evidence (“VOE”) (now referred to as “TPE” or third-party evidence) for determining the selling price of a deliverable. A vendor is now required to use its best estimate of the selling price when more objective evidence of the selling price cannot be determined. By providing an alternative for determining the selling price of deliverables, this guidance allows companies to allocate arrangement consideration in multiple deliverable arrangements in a manner that better reflects the transaction’s economics. In addition, the residual method of allocating arrangement consideration is no longer permitted under this new guidance. We have adopted this guidance effective January 1, 2011, and will apply it on a prospective basis for all new or materially modified revenue arrangements with multiple deliverables entered into on or after January 1, 2011. Because we did not enter into any new or materially modified agreements with multiple elements and fixed payments in the six months ended June 30, 2011 that would have been impacted by this guidance, the adoption did not have a material impact on the timing or pattern of revenue recognition.	

9

Table of Contents
 	 	 	For the year ended December 31, 2010, there would have been no change in revenue recognized relating to multiple-element arrangements if we had adopted this guidance retrospectively for contracts entered into prior to January 1, 2011.	
Goodwill Impairment Testing. In December 2010, the FASB issued the following guidance which modifies goodwill impairment testing. Effective for interim and annual reporting beginning on or after December 15, 2010, we adopted this guidance in full effective January 1, 2011.
 	•	 	ASU No. 2010-28, Intangibles—Goodwill and Other (ASC Topic 350) — When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts,  a consensus of the FASB Emerging Issues Task Force. This guidance modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The adoption of this guidance did not impact our consolidated financial position, results of operations or cash flows.	
Presentation of Financial Statements. In June 2011, the FASB and International Accounting Standards Board, or IASB, issued the following guidance which modifies how other comprehensive income, or OCI, is reported under U.S. Generally Accepted Accounting Principles, or GAAP, and International Financial Reporting Standards, or IFRS. This guidance is effective for interim and annual reporting beginning on or after December 15, 2011.
 	•	 	ASU No. 2011-05, Comprehensive Income (ASC Topic 220) — Presentation of Comprehensive Income,  a consensus of the FASB Emerging Issues Task Force. This guidance eliminates the option to present components of OCI as part of the statement of changes to stockholders’ equity. All filers are required to present all non-owner changes in stockholders’ equity in a single statement of comprehensive income or in two separate but consecutive statements. We do not expect the adoption of this guidance to impact our consolidated financial position, results of operations or cash flows.	
Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, or AICPA, and the Securities and Exchange Commission, or SEC, did not have, or are not believed by management to have, a material impact on our present or future consolidated financial statements.
3. Earnings per Share
The denominators for the computation of basic and diluted earnings per share were calculated as follows:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	 	Six Months Ended	 	
 	 	June 30,	 	 	June 30,	 	
 	 	2011	 	 	2010	 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
Shares outstanding at the beginning of the period	 	 	45,828	 	 	 	38,592	 	 	 	45,463	 	 	 	38,410	 	
Weighted-average number of shares issued	 	 	69	 	 	 	19	 	 	 	280	 	 	 	131	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Denominator for basic earnings per share	 	 	45,897	 	 	 	38,611	 	 	 	45,743	 	 	 	38,541	 	
Dilutive effect of employee stock options and stock grants (1)	 	 	574	 	 	 	315	 	 	 	649	 	 	 	388	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Denominator for diluted earnings per share (2)	 	 	46,471	 	 	 	38,926	 	 	 	46,392	 	 	 	38,929	 	

 	 	 	
(1)	 	Options to purchase common shares are included in the calculation of diluted earnings per share when their exercise prices are below the average fair value of the common shares for each of the periods presented. For the three months ended June 30, 2011, and 2010, there were approximately 81,200 and 724,500 antidilutive weighted options, respectively. For the six months ended June 30, 2011, and 2010, there were approximately 122,100 and 745,500 antidilutive weighted options, respectively. Restricted shares are included in the calculation of diluted earnings per share when their grant date fair values are below the average fair value of the common shares for each of the periods presented. There were no antidilutive weighted restricted shares for the three months and six months ended June 30, 2011. For the three months and six months ended June 30, 2010, there were approximately 1,500, and 13,500 antidilutive weighted restricted shares, respectively.	

10

Table of Contents
 	 	 	
(2)	 	Potentially dilutive shares issuable pursuant to our convertible senior notes were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the three month and six month periods ended June 30, 2011 and 2010.	
4. Share-Based Compensation
At June 30, 2011, we had employee equity incentives outstanding under two plans: (1) the 2002 Equity Incentive Plan; and (2) the 2000 Omnibus Stock and Incentive Plan (from which equity incentives are no longer awarded). On March 1, 2011, our chief executive officer, chief financial officer, and chief operating officer were awarded 150,000 shares, 112,500 shares, and 27,000 shares, respectively, of restricted stock with performance and service conditions. Each of the grants shall vest on March 1, 2012, provided that: (i) the Company’s total operating revenue for 2011 is equal to or greater than $3.7 billion, and (ii) the respective officer continues to be employed by the Company as of March 1, 2012. In the event both vesting conditions are not achieved, the equity compensation awards shall lapse. As of June 30, 2011, we expect these awards to vest in full.
Charged to general and administrative expenses, total stock-based compensation expense was as follows for the three month and six month periods ended June 30, 2011 and 2010:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	 	Six Months Ended	 	
 	 	June 30,	 	 	June 30,	 	
 	 	2011	 	 	2010	 	 	2011	 	 	2010	 	
 	 	(in thousands)	 	
Restricted stock awards	 	$	3,932	 	 	$	2,106	 	 	$	7,738	 	 	$	3,745	 	
Stock options (including shares issued under our employee stock purchase plan)	 	 	378	 	 	 	265	 	 	 	636	 	 	 	763	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total stock-based compensation expense	 	$	4,310	 	 	$	2,371	 	 	$	8,374	 	 	$	4,508	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
As of June 30, 2011, there was $22.0 million of total unrecognized compensation expense related to unvested restricted stock awards, which we expect to recognize over a remaining weighted-average period of 2.2 years. As of June 30, 2011, there was no remaining unrecognized compensation expense related to unvested stock options.
Unvested restricted stock and restricted stock activity for the six months ended June 30, 2011 is summarized below:
 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Weighted	 	
 	 	 	 	 	 	Average	 	
 	 	 	 	 	 	Grant Date	 	
 	 	Shares	 	 	Fair Value	 	
Unvested balance as of December 31, 2010	 	 	1,253,624	 	 	$	15.55	 	
Granted	 	 	754,800	 	 	 	23.53	 	
Vested	 	 	(450,324	)	 	 	16.88	 	
Forfeited	 	 	(53,029	)	 	 	15.22	 	
 	 	 	 	 	 	 	 	
Unvested balance as of June 30, 2011	 	 	1,505,071	 	 	 	19.16	 	
 	 	 	 	 	 	 	 	
The total fair value of restricted shares granted during the six months ended June 30, 2011 and 2010 was $17.7 million and $11.2 million, respectively. The total fair value of restricted shares vested during the six months ended June 30, 2011 and 2010 was $10.9 million and $4.6 million, respectively.

11

Table of Contents
Stock option activity for the six months ended June 30, 2011 is summarized below:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	Weighted	 	
 	 	 	 	 	 	Weighted	 	 	 	 	 	 	Average	 	
 	 	 	 	 	 	Average	 	 	Average	 	 	Remaining	 	
 	 	 	 	 	 	Grant Date	 	 	Intrinsic	 	 	Contractual	 	
 	 	Shares	 	 	Fair Value	 	 	Value	 	 	term	 	
 	 	 	 	 	 	 	 	 	 	(In thousands)	 	 	(Years)	 	
Stock options outstanding as of December 31, 2010	 	 	770,421	 	 	$	20.39	 	 	 	 	 	 	 	 	 	
Exercised	 	 	(185,672	)	 	 	19.23	 	 	 	 	 	 	 	 	 	
Forfeited	 	 	(8,275	)	 	 	22.29	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Stock options outstanding as of June 30, 2011	 	 	576,474	 	 	 	20.75	 	 	$	3,839	 	 	 	4.4	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Stock options exercisable and expected to vest as of June 30, 2011	 	 	576,369	 	 	 	20.75	 	 	$	3,838	 	 	 	4.3	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Exercisable as of June 30, 2011	 	 	570,849	 	 	 	20.72	 	 	$	3,817	 	 	 	4.4	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	
5. Fair Value Measurements
Our consolidated balance sheets include the following financial instruments: cash and cash equivalents, investments, receivables, trade accounts payable, medical claims and benefits payable, long-term debt, and other liabilities. We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For a comprehensive discussion of fair value measurements with regard to our current and non-current investments, see below.
The carrying amount of the convertible senior notes was $166.7 million and $164.0 million as of June 30, 2011, and December 31, 2010, respectively. Based on quoted market prices, the fair value of the convertible senior notes was approximately $215.8 million and $188.4 million as of June 30, 2011, and December 31, 2010, respectively.
To prioritize the inputs we use in measuring fair value, we apply a three-tier fair value hierarchy. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.
As of June 30, 2011, we held certain assets that are required to be measured at fair value on a recurring basis. These included current investments in investment-grade debt securities that are designated as available-for-sale, and are reported at fair value based on market prices that are readily available (Level 1). See Note 6, “Investments,” for further information regarding fair value.
We also held investments in auction rate securities which are designated as available-for-sale, and are reported at fair value of $19.0 million (par value of $22.4 million) as of June 30, 2011.
Our investments in auction rate securities are collateralized by student loan portfolios guaranteed by the U.S. government. We continued to earn interest on substantially all of these auction rate securities as of June 30, 2011. Due to events in the credit markets, the auction rate securities held by us experienced failed auctions beginning in the first quarter of 2008. As such, quoted prices in active markets were not readily available during the majority of 2008, 2009, and 2010, and continued to be unavailable as of June 30, 2011. To estimate the fair value of these securities, we used pricing models that included factors such as the collateral underlying the securities, the creditworthiness of the counterparty, the timing of expected future cash flows, and the expectation of the next time the security would have a successful auction. The estimated values of these securities were also compared, when possible, to valuation data with respect to similar securities held by other parties. We concluded that these estimates, given the lack of market available pricing, provided a reasonable basis for determining the fair value of the auction rate securities as of June 30, 2011. For our investments in auction rate securities, we do not intend to sell, nor is it more likely than not that we will be required to sell, these investments before recovery of their cost.

12

Table of Contents
As a result of changes in the fair value of auction rate securities designated as available-for-sale, we recorded pretax unrealized gains of $0.7 million and pretax unrealized losses of $0.2 million to accumulated other comprehensive income (loss) for the six months ended June 30, 2011, and 2010, respectively. Any future fluctuation in fair value related to these instruments that we deem to be temporary, including any recoveries of previous write-downs, would be recorded to accumulated other comprehensive income (loss). If we determine that any future valuation adjustment was other-than-temporary, we would record a charge to earnings as appropriate.
Until July 2, 2010, we held certain auction rate securities (designated as trading securities) with an investment securities firm. In 2008, we entered into a rights agreement with this firm that (1) allowed us to exercise rights (the “Rights”) to sell the eligible auction rate securities at par value to this firm between June 30, 2010 and July 2, 2012, and (2) gave the investment securities firm the right to purchase the auction rate securities from us any time after the agreement date as long as we received the par value. On June 30, 2010, and July 1, 2010, all of the eligible auction rate securities remaining at that time were settled at par value. During 2010, the aggregate auction rate securities (designated as trading securities) settled amounted to $40.9 million par value (fair value $36.7 million). Substantially all of the difference between par value and fair value on these securities was recovered through the rights agreement. For the six months ended 2010, we recorded pretax gains of $2.9 million on the auction rate securities underlying the Rights.
We accounted for the Rights as a freestanding financial instrument and, until July 2, 2010, recorded the value of the Rights under the fair value option. For the six months ended 2010, we recorded pretax losses of $2.6 million on the Rights, attributable to the decline in the fair value of the Rights. When the remaining eligible auction rate securities were sold at par value on July 1, 2010, the value of the Rights was zero.
Our assets measured at fair value on a recurring basis at June 30, 2011, were as follows:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Total	 	 	Level 1	 	 	Level 2	 	 	Level 3	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	243,277	 	 	$	243,277	 	 	$	—	 	 	$	—	 	
Government-sponsored enterprise securities (GSEs)	 	 	36,797	 	 	 	36,797	 	 	 	—	 	 	 	—	 	
Municipal securities	 	 	41,028	 	 	 	41,028	 	 	 	—	 	 	 	—	 	
U.S. treasury notes	 	 	32,240	 	 	 	32,240	 	 	 	—	 	 	 	—	 	
Certificates of deposit	 	 	3,258	 	 	 	3,258	 	 	 	—	 	 	 	—	 	
Auction rate securities	 	 	18,958	 	 	 	—	 	 	 	—	 	 	 	18,958	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	375,558	 	 	$	356,600	 	 	$	—	 	 	$	18,958	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
The following table presents our assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
 	 	 	 	 	
 	 	(Level 3)	 	
 	 	(In thousands)	 	
Balance at December 31, 2010	 	$	20,449	 	
Total gains (realized or unrealized):	 	 	 	 	
Included in other comprehensive income	 	 	659	 	
Settlements	 	 	(2,150	)	
 	 	 	 	
Balance at June 30, 2011	 	$	18,958	 	

The amount of total gains for the period included in other comprehensive income attributable to the change in unrealized gains relating to assets still held at June 30, 2011	 	$	659	 	

13

Table of Contents
In 2010, we recorded a $2.8 million liability for contingent consideration related to the acquisition of our Wisconsin health plan. In the first quarter of 2011, we determined that there was no liability for contingent consideration relating to the acquisition. The liability for contingent consideration related to this acquisition was measured at fair value on a recurring basis using significant unobservable inputs (Level 3). The following table presents a roll forward of this liability for 2011:
 	 	 	 	 	
 	 	(Level 3)	 	
 	 	(In thousands)	 	
Balance at December 31, 2010	 	$	(2,800	)	
Total gains included in earnings	 	 	2,800	 	
 	 	 	 	
Balance at June 30, 2011	 	$	—	 	
 	 	 	 	
6. Investments
The following tables summarize our investments as of the dates indicated:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	June 30, 2011	 	
 	 	 	 	 	 	Gross	 	 	Estimated	 	
 	 	 	 	 	 	Unrealized	 	 	Fair	 	
 	 	Cost	 	 	Gains	 	 	Losses	 	 	Value	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	246,215	 	 	$	230	 	 	$	3,168	 	 	$	243,277	 	
GSEs	 	 	36,917	 	 	 	50	 	 	 	170	 	 	 	36,797	 	
Municipal securities (including non-current auction rate securities)	 	 	63,772	 	 	 	70	 	 	 	3,856	 	 	 	59,986	 	
U.S. treasury notes	 	 	32,132	 	 	 	119	 	 	 	11	 	 	 	32,240	 	
Certificates of deposit	 	 	3,258	 	 	 	—	 	 	 	—	 	 	 	3,258	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	382,294	 	 	$	469	 	 	$	7,205	 	 	$	375,558	 	

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	December 31, 2010	 	
 	 	 	 	 	 	Gross	 	 	Estimated	 	
 	 	 	 	 	 	Unrealized	 	 	Fair	 	
 	 	Cost	 	 	Gains	 	 	Losses	 	 	Value	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	179,124	 	 	$	193	 	 	$	1,388	 	 	$	177,929	 	
GSEs	 	 	59,790	 	 	 	293	 	 	 	370	 	 	 	59,713	 	
Municipal securities (including non-current auction rate securities)	 	 	55,247	 	 	 	78	 	 	 	4,313	 	 	 	51,012	 	
U.S. treasury notes	 	 	23,864	 	 	 	114	 	 	 	60	 	 	 	23,918	 	
Certificates of deposit	 	 	3,252	 	 	 	—	 	 	 	—	 	 	 	3,252	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	321,277	 	 	$	678	 	 	$	6,131	 	 	$	315,824	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
The contractual maturities of our investments as of June 30, 2011 are summarized below:
 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Estimated	 	
 	 	Cost	 	 	Fair Value	 	
 	 	(In thousands)	 	
Due in one year or less	 	$	190,202	 	 	$	188,005	 	
Due one year through five years	 	 	170,192	 	 	 	169,025	 	
Due after ten years	 	 	21,900	 	 	 	18,528	 	
 	 	 	 	 	 	 	
 	 	$	382,294	 	 	$	375,558	 	

14

Table of Contents
Gross realized gains and gross realized losses from sales of available-for-sale securities are calculated under the specific identification method and are included in investment income. Total proceeds from sales and maturities of available-for-sale securities were $60.1 million and $42.8 million for the three months ended June 30, 2011, and 2010, respectively. Total proceeds from sales and maturities of available-for-sale securities were $121.4 million and $91.3 million for the six months ended June 30, 2011, and 2010, respectively. Net realized investment gains for the three months ended June 30, 2011, and 2010 were $21,000 and $43,000 respectively. Net realized investment gains for the six months ended June 30, 2011, and 2010 were $178,000 and $57,000 respectively.
We monitor our investments for other-than-temporary impairment. For investments other than our municipal securities, we have determined that unrealized gains and losses at June 30, 2011, and December 31, 2010, are temporary in nature, because the change in market value for these securities has resulted from fluctuating interest rates, rather than a deterioration of the credit worthiness of the issuers. So long as we hold these securities to maturity, we are unlikely to experience gains or losses. In the event that we dispose of these securities before maturity, we expect that realized gains or losses, if any, will be immaterial.
Approximately 32% of our investment in municipal securities consists of auction rate securities. As described in Note 5, “Fair Value Measurements,” the unrealized losses on these investments were caused primarily by the illiquidity in the auction markets. Because the decline in market value is not due to the credit quality of the issuers, and because we do not intend to sell, nor is it more likely than not that we will be required to sell, these investments before recovery of their cost, we do not consider the auction rate securities that are designated as available-for-sale to be other-than-temporarily impaired at June 30, 2011.
The following tables segregate those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of June 30, 2011.
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	In a Continuous Loss	 	 	In a Continuous Loss	 	 	 	 	
 	 	Position	 	 	Position	 	 	 	 	
 	 	for Less than 12 Months	 	 	for 12 Months or More	 	 	Total	 	
 	 	Estimated	 	 	 	 	 	 	Estimated	 	 	 	 	 	 	Estimated	 	 	 	 	
 	 	Fair	 	 	Unrealized	 	 	Fair	 	 	Unrealized	 	 	Fair	 	 	Unrealized	 	
 	 	Value	 	 	Losses	 	 	Value	 	 	Losses	 	 	Value	 	 	Losses	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	159,261	 	 	$	2,881	 	 	$	12,715	 	 	$	287	 	 	$	171,976	 	 	$	3,168	 	
GSEs	 	 	14,745	 	 	 	102	 	 	 	2,034	 	 	 	68	 	 	 	16,779	 	 	 	170	 	
Municipal securities	 	 	28,335	 	 	 	270	 	 	 	24,199	 	 	 	3,585	 	 	 	52,534	 	 	 	3,855	 	
U.S. treasury notes	 	 	1,155	 	 	 	1	 	 	 	2,059	 	 	 	11	 	 	 	3,214	 	 	 	12	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	203,496	 	 	$	3,254	 	 	$	41,007	 	 	$	3,951	 	 	$	244,503	 	 	$	7,205	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
The following table segregates those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of December 31, 2010.
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	In a Continuous Loss	 	 	In a Continuous Loss	 	 	 	 	
 	 	Position	 	 	Position	 	 	 	 	
 	 	for Less than 12 Months	 	 	for 12 Months or More	 	 	Total	 	
 	 	Estimated	 	 	 	 	 	 	Estimated	 	 	 	 	 	 	Estimated	 	 	 	 	
 	 	Fair	 	 	Unrealized	 	 	Fair	 	 	Unrealized	 	 	Fair	 	 	Unrealized	 	
 	 	Value	 	 	Losses	 	 	Value	 	 	Losses	 	 	Value	 	 	Losses	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	103,225	 	 	$	1,060	 	 	$	10,490	 	 	$	328	 	 	$	113,715	 	 	$	1,388	 	
GSEs	 	 	13,014	 	 	 	71	 	 	 	7,539	 	 	 	299	 	 	 	20,553	 	 	 	370	 	
Municipal securities	 	 	18,884	 	 	 	117	 	 	 	25,271	 	 	 	4,196	 	 	 	44,155	 	 	 	4,313	 	
U.S. treasury notes	 	 	5,480	 	 	 	40	 	 	 	6,806	 	 	 	20	 	 	 	12,286	 	 	 	60	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	140,603	 	 	$	1,288	 	 	$	50,106	 	 	$	4,843	 	 	$	190,709	 	 	$	6,131	 	

15

Table of Contents
7. Receivables
Health Plans segment receivables consist primarily of amounts due from the various states in which we operate. Such receivables are subject to potential retroactive adjustment. Because all of our receivable amounts are readily determinable and our creditors are in almost all instances state governments, our allowance for doubtful accounts is immaterial. Any amounts determined to be uncollectible are charged to expense when such determination is made. Accounts receivable were as follows:
 	 	 	 	 	 	 	 	 	
 	 	June 30,	 	 	December 31,	 	
 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
Health Plans segment:	 	 	 	 	 	 	 	 	
California	 	$	30,501	 	 	$	46,482	 	
Michigan	 	 	14,974	 	 	 	13,596	 	
Missouri	 	 	23,848	 	 	 	22,841	 	
New Mexico	 	 	9,629	 	 	 	18,310	 	
Ohio	 	 	19,511	 	 	 	21,622	 	
Utah	 	 	5,634	 	 	 	1,589	 	
Washington	 	 	12,371	 	 	 	14,486	 	
Wisconsin	 	 	8,511	 	 	 	5,437	 	
Others	 	 	3,796	 	 	 	3,598	 	
 	 	 	 	 	 	 	
Total Health Plans segment	 	 	128,775	 	 	 	147,961	 	
Molina Medicaid Solutions segment	 	 	43,899	 	 	 	20,229	 	
 	 	 	 	 	 	 	
 	 	$	172,674	 	 	$	168,190	 	
 	 	 	 	 	 	 	
During the second quarter of 2011, we settled certain claims we had made against the state of Utah regarding the savings share provision of our contract in effect from 2003 through June of 2009. Additionally, we recognized a liability for certain overpayments received from the state for the period 2003 through 2009. As a result of these developments, we recognized $6.9 million in premium revenue without any corresponding charge to expense during the second quarter of 2011.
8. Restricted Investments
Pursuant to the regulations governing our Health Plan subsidiaries, we maintain statutory deposits and deposits required by state Medicaid authorities in certificates of deposit and U.S. treasury securities. Additionally, we maintain restricted investments as protection against the insolvency of capitated providers. The following table presents the balances of restricted investments by health plan, and for our insurance company:
 	 	 	 	 	 	 	 	 	
 	 	June 30,	 	 	December 31,	 	
 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
California	 	$	372	 	 	$	372	 	
Florida	 	 	8,044	 	 	 	4,508	 	
Insurance Company	 	 	4,680	 	 	 	4,689	 	
Michigan	 	 	1,000	 	 	 	1,000	 	
Missouri	 	 	506	 	 	 	508	 	
New Mexico	 	 	15,894	 	 	 	15,881	 	
Ohio	 	 	9,076	 	 	 	9,066	 	
Texas	 	 	3,500	 	 	 	3,501	 	
Utah	 	 	2,787	 	 	 	1,279	 	
Washington	 	 	151	 	 	 	151	 	
Wisconsin	 	 	—	 	 	 	260	 	
Other	 	 	4,320	 	 	 	885	 	
 	 	 	 	 	 	 	
 	 	$	50,330	 	 	$	42,100	 	

16

Table of Contents
The contractual maturities of our held-to-maturity restricted investments as of June 30, 2011 are summarized below.
 	 	 	 	 	 	 	 	 	
 	 	Amortized	 	 	Estimated	 	
 	 	Cost	 	 	Fair Value	 	
 	 	(In thousands)	 	
Due in one year or less	 	$	46,732	 	 	$	46,756	 	
Due one year through five years	 	 	3,598	 	 	 	3,642	 	
 	 	 	 	 	 	 	
 	 	$	50,330	 	 	$	50,398	 	
 	 	 	 	 	 	 	
9. Long-Term Debt
Credit Facility
We are a party to an Amended and Restated Credit Agreement, dated as of March 9, 2005, as amended by the first amendment on October 5, 2005, the second amendment on November 6, 2006, the third amendment on May 25, 2008, the fourth amendment on April 29, 2010, and the fifth amendment on April 29, 2010, among Molina Healthcare Inc., certain lenders, and Bank of America N.A., as Administrative Agent (the “Credit Facility”) for a revolving credit line of $150 million that matures in May 2012. The Credit Facility is intended to be used for general corporate purposes. As of June 30, 2011, and December 31, 2010, there was no outstanding principal balance under the Credit Facility. However, as of June 30, 2011, our lenders had issued two letters of credit in the aggregate principal amount of $10.3 million in connection with the Molina Medicaid Solutions contracts with the states of Maine and Idaho.
To the extent that in the future we incur any obligations under the Credit Facility, such obligations will be secured by a lien on substantially all of our assets and by a pledge of the capital stock of our health plan subsidiaries (with the exception of the California health plan). The Credit Facility includes usual and customary covenants for credit facilities of this type, including covenants limiting liens, mergers, asset sales, other fundamental changes, debt, acquisitions, dividends and other distributions, capital expenditures, investments, and a fixed charge coverage ratio. The Credit Facility also requires us to maintain a ratio of total consolidated debt to total consolidated EBITDA of not more than 2.75 to 1.00 at any time. At June 30, 2011, we were in compliance with all financial covenants in the Credit Facility.
The commitment fee on the total unused commitments of the lenders under the Credit Facility is 50 basis points on all levels of the pricing grid, with the pricing grid referring to our ratio of consolidated funded debt to consolidated EBITDA. The pricing for LIBOR loans and base rate loans is 200 basis points at every level of the pricing grid. Thus, the applicable margins under the Credit Facility range between 2.75% and 3.75% for LIBOR loans, and between 1.75% and 2.75% for base rate loans. The Credit Facility carves out from our indebtedness and restricted payment covenants under the Credit Facility the $187.0 million current principal amount of the convertible senior notes, although the $187.0 million indebtedness is included in the calculation of our consolidated leverage ratio. The fixed charge coverage ratio under the Credit Facility is required to be no less than 3.00x.
The fifth amendment increased the maximum consolidated leverage ratio under the Credit Facility to 3.50 to 1.0 for the first and second quarters of 2010 and through August 14, 2010 (on a pro forma basis). Effective as of August 15, 2010, the maximum consolidated leverage ratio under the Credit Facility reverted back to 2.75 to 1.0.
Convertible Senior Notes
As of June 30, 2011, $187.0 million in aggregate principal amount of our 3.75% Convertible Senior Notes due 2014 (the “Notes”) remain outstanding. The Notes rank equally in right of payment with our existing and future senior indebtedness. The Notes are convertible into cash and, under certain circumstances, shares of our common stock. The initial conversion rate is 31.9601 shares of our common stock per one thousand dollar principal amount of the Notes. This represents an initial conversion price of approximately $31.29 per share of our common stock. In addition, if certain corporate transactions that constitute a change of control occur prior to maturity, we will increase the conversion rate in certain circumstances.

17

Table of Contents
The proceeds from the issuance of the Notes have been allocated between a liability component and an equity component. We have determined that the effective interest rate of the Notes is 7.5%, principally based on the seven-year U.S. treasury note rate as of the October 2007 issuance date, plus an appropriate credit spread. The resulting debt discount is being amortized over the period the Notes are expected to be outstanding, as additional non-cash interest expense. As of June 30, 2011, we expect the Notes to be outstanding until their October 1, 2014 maturity date, for a remaining amortization period of 39 months. The Notes’ if-converted value did not exceed their principal amount as of June 30, 2011. At June 30, 2011, the equity component of the Notes, net of the impact of deferred taxes, was $24.0 million. The following table provides the details of the liability amounts recorded:
 	 	 	 	 	 	 	 	 	
 	 	As of	 	 	As of	 	
 	 	June 30,	 	 	December 31,	 	
 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
Details of the liability component:	 	 	 	 	 	 	 	 	
Principal amount	 	$	187,000	 	 	$	187,000	 	
Unamortized discount	 	 	(20,275	)	 	 	(22,986	)	
 	 	 	 	 	 	 	
Net carrying amount	 	$	166,725	 	 	$	164,014	 	

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	 	Six Months Ended	 	
 	 	June 30,	 	 	June 30,	 	
 	 	2011	 	 	2010	 	 	2011	 	 	2010	 	
 	 	(in thousands)	 	
Interest cost recognized for the period relating to the:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Contractual interest coupon rate of 3.75%	 	$	1,753	 	 	$	1,753	 	 	$	3,506	 	 	$	3,506	 	
Amortization of the discount on the liability component	 	 	1,371	 	 	 	1,266	 	 	 	2,711	 	 	 	2,509	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total interest cost recognized	 	$	3,124	 	 	$	3,019	 	 	$	6,217	 	 	$	6,015	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
10. Stockholders’ Equity
On April 27, 2011, we announced that our board of directors authorized a 3-for-2 stock split of our common stock to be effected in the form of a stock dividend of one share of our stock for every two shares outstanding. The dividend was distributed on May 20, 2011.
In connection with the plans described in Note 4, “Share-Based Compensation,” we issued approximately 599,000 shares of common stock, net of shares retired to settle employees’ income tax obligations, for the six months ended June 30, 2011. For the six months ended June 30, 2011, the $11.4 million increase in additional paid-in capital was primarily generated by employee stock plan transactions.
11. Segment Reporting
Our reportable segments are consistent with how we manage the business and view the markets we serve. In the second quarter of 2010, we added a segment to our internal financial reporting structure as a result of the acquisition of Molina Medicaid Solutions. We report our financial performance based on two reportable segments: Health Plans and Molina Medicaid Solutions.
We rely on an internal management reporting process that provides segment information to the operating income level for purposes of making financial decisions and allocating resources. The accounting policies of the segments are the same as those described in Note 2, “Significant Accounting Policies.” The cost of services shared between the Health Plans and Molina Medicaid Solutions segments is charged to the Health Plans segment.

18

Table of Contents
Molina Medicaid Solutions was acquired on May 1, 2010; therefore, the three months and six months ended June 30, 2011 include only two months of operating results for this segment. Operating segment revenues and profitability for the three months and six months ended June 30, 2011 and 2010 were as follows:
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Molina	 	 	 	 	
 	 	 	 	 	 	Medicaid	 	 	 	 	
 	 	Health Plans	 	 	Solutions	 	 	Total	 	
 	 	(In thousands)	 	
Three months ended June 30, 2011	 	 	 	 	 	 	 	 	 	 	 	 	
Premium revenue	 	$	1,128,770	 	 	$	—	 	 	$	1,128,770	 	
Service revenue	 	 	—	 	 	 	36,888	 	 	 	36,888	 	
Investment income	 	 	1,446	 	 	 	—	 	 	 	1,446	 	
 	 	 	 	 	 	 	 	 	 	
Total revenue	 	$	1,130,216	 	 	$	36,888	 	 	$	1,167,104	 	
 	 	 	 	 	 	 	 	 	 	
Operating income (loss)	 	$	36,894	 	 	$	(5,484	)	 	$	31,410	 	

Six months ended June 30, 2011	 	 	 	 	 	 	 	 	 	 	 	 	
Premium revenue	 	$	2,210,208	 	 	$	—	 	 	$	2,210,208	 	
Service revenue	 	 	—	 	 	 	73,562	 	 	 	73,562	 	
Investment income	 	 	3,040	 	 	 	—	 	 	 	3,040	 	
 	 	 	 	 	 	 	 	 	 	
Total revenue	 	$	2,213,248	 	 	$	73,562	 	 	$	2,286,810	 	
 	 	 	 	 	 	 	 	 	 	
Operating income (loss)	 	$	66,500	 	 	$	(3,790	)	 	$	62,710	 	

Three months ended June 30, 2010	 	 	 	 	 	 	 	 	 	 	 	 	
Premium revenue	 	$	976,685	 	 	$	—	 	 	$	976,685	 	
Service revenue	 	 	—	 	 	 	21,054	 	 	 	21,054	 	
Investment income	 	 	1,599	 	 	 	—	 	 	 	1,599	 	
 	 	 	 	 	 	 	 	 	 	
Total revenue	 	$	978,284	 	 	$	21,054	 	 	$	999,338	 	
 	 	 	 	 	 	 	 	 	 	
Operating income	 	$	16,173	 	 	$	5,005	 	 	$	21,178	 	

Six months ended June 30, 2010	 	 	 	 	 	 	 	 	 	 	 	 	
Premium revenue	 	$	1,941,905	 	 	$	—	 	 	$	1,941,905	 	
Service revenue	 	 	—	 	 	 	21,054	 	 	 	21,054	 	
Investment income	 	 	3,120	 	 	 	—	 	 	 	3,120	 	
 	 	 	 	 	 	 	 	 	 	
Total revenue	 	$	1,945,025	 	 	$	21,054	 	 	$	1,966,079	 	
 	 	 	 	 	 	 	 	 	 	
Operating income	 	$	36,611	 	 	$	5,005	 	 	$	41,616	 	
 	 	 	 	 	 	 	 	 	 	
Reconciliation to Income before Income Taxes
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	 	Six Months Ended	 	
 	 	June 30,	 	 	June 30,	 	
 	 	2011	 	 	2010	 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
Segment operating income	 	$	31,410	 	 	$	21,178	 	 	$	62,710	 	 	$	41,616	 	
Interest expense	 	 	(3,683	)	 	 	(4,099	)	 	 	(7,286	)	 	 	(7,456	)	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Income before income taxes	 	$	27,727	 	 	$	17,079	 	 	$	55,424	 	 	$	34,160	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Segment Assets
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Molina	 	 	 	 	
 	 	 	 	 	 	Medicaid	 	 	 	 	
 	 	Health Plans	 	 	Solutions	 	 	Total	 	
 	 	(In thousands)	 	
As of June 30, 2011	 	$	1,382,365	 	 	$	218,056	 	 	$	1,600,421	 	
 	 	 	 	 	 	 	 	 	 	
As of December 31, 2010	 	$	1,333,599	 	 	$	175,615	 	 	$	1,509,214	 	

19

Table of Contents
12. Commitments and Contingencies
Legal
The health care industry is subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines, exclusion from participating in publicly funded programs, and the repayment of previously billed and collected revenues.
We are involved in various legal actions in the normal course of business, some of which seek monetary damages, including claims for punitive damages, which are not covered by insurance. These actions, when finally concluded and determined, are not likely, in our opinion, to have a material adverse effect on our business, consolidated financial position, cash flows, or results of operations.
Provider Claims
Many of our medical contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations have led certain medical providers to pursue us for additional compensation. The claims made by providers in such circumstances often involve issues of contract compliance, interpretation, payment methodology, and intent. These claims often extend to services provided by the providers over a number of years.
Various providers have contacted us seeking additional compensation for claims that we believe to have been settled. These matters, when finally concluded and determined, will not, in our opinion, have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows.
Regulatory Capital and Dividend Restrictions
Our health plans are subject to state laws and regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent the subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. The net assets in these subsidiaries (after intercompany eliminations) which may not be transferable to us in the form of loans, advances, or cash dividends was $438.5 million at June 30, 2011, and $397.8 million at December 31, 2010.
The National Association of Insurance Commissioners, or NAIC, adopted rules effective December 31, 1998, which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for health care coverage. The requirements take the form of risk-based capital (RBC) rules. Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin have adopted these rules, which may vary from state to state. California and Florida have not yet adopted NAIC risk-based capital requirements for HMOs and have not formally given notice of their intention to do so. Such requirements, if adopted by California and Florida, may increase the minimum capital required for those states.
As of June 30, 2011, our health plans had aggregate statutory capital and surplus of approximately $448.0 million compared with the required minimum aggregate statutory capital and surplus of approximately $273.6 million. All of our health plans were in compliance with the minimum capital requirements at June 30, 2011. We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements.

20

Table of Contents
13. Related Party Transactions
We have an equity investment in a medical service provider that provides certain vision services to our members. We account for this investment under the equity method of accounting because we have an ownership interest in the investee that confers significant influence over operating and financial policies of the investee. As of both June 30, 2011, and December 31, 2010, our carrying amount for this investment totaled $4.4 million. For the three months ended June 30, 2011 and 2010, we paid $6.6 million, and $5.3 million, respectively, for medical service fees to this provider. For the six months ended June 30, 2011 and 2010, we paid $11.9 million, and $9.7 million, respectively, for medical service fees to this provider.

21

Table of Contents
 	 	 	
Item 2.	 	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	
Forward Looking Statements
This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, or Securities Act, and Section 21E of the Securities Exchange Act of 1934, or Securities Exchange Act. All statements, other than statements of historical facts, included in this quarterly report may be deemed to be forward-looking statements for purposes of the Securities Act and the Securities Exchange Act. We use the words “anticipate(s),” “believe(s),” “estimate(s),” “expect(s),” “intend(s),” “may,” “plan(s),” “project(s),” “will,” “would,” and similar expressions to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We cannot guarantee that we will actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and, accordingly, you should not place undue reliance on our forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from the forward-looking statements that we make. You should read these factors and the other cautionary statements as being applicable to all related forward-looking statements wherever they appear in this quarterly report. We caution you that we do not undertake any obligation to update forward-looking statements made by us. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected, estimated, expected, or contemplated as a result of, but not limited to, risk factors related to the following:
•	 	significant budget pressures on state governments and their potential inability to maintain current rates, to implement expected rate increases, or to maintain existing benefit packages or membership eligibility thresholds or criteria;	

•	 	uncertainties regarding the impact of the Patient Protection and Affordable Care Act, including its possible repeal, judicial overturning of the individual insurance mandate, the effect of various implementing regulations, and uncertainties regarding the likely impact of other federal or state health care and insurance reform measures;	

•	 	management of our medical costs, including seasonal flu patterns and rates of utilization that are consistent with our expectations;	

•	 	the success of our efforts to retain existing government contracts and to obtain new government contracts in connection with state requests for proposals (RFPs) in both existing and new states, and our ability to grow our revenues consistent with our expectations;	

•	 	the accurate estimation of incurred but not reported medical costs across our health plans;	

•	 	risks associated with the continued growth in new Medicaid and Medicare enrollees;	

•	 	retroactive adjustments to premium revenue or accounting estimates which require adjustment based upon subsequent developments, including Medicaid pharmaceutical rebates;	

•	 	the continuation and renewal of the government contracts of both our health plans and Molina Medicaid Solutions and the terms under which such contracts are renewed;	

•	 	the timing of receipt and recognition of revenue and the amortization of expense under the state contracts of Molina Medicaid Solutions in Maine and Idaho;	

•	 	additional administrative costs and the potential payment of additional amounts to providers and/or the state by Molina Medicaid Solutions as a result of MMIS implementation issues in Idaho;	

•	 	government audits and reviews, including the audit of our Medicare plans by CMS;	

•	 	changes with respect to our provider contracts and the loss of providers;	

22

Table of Contents
•	 	the establishment of a federal or state medical cost expenditure floor as a percentage of the premiums we receive, and the interpretation and implementation of medical cost expenditure floors, administrative cost and profit ceilings, and profit sharing arrangements;	

•	 	the interpretation and implementation of at-risk premium rules regarding the achievement of certain quality measures;	

•	 	approval by state regulators of dividends and distributions by our health plan subsidiaries;	

•	 	changes in funding under our contracts as a result of regulatory changes, programmatic adjustments, or other reforms;	

•	 	high dollar claims related to catastrophic illness;	

•	 	the favorable resolution of litigation or arbitration matters;	

•	 	restrictions and covenants in our credit facility;	

•	 	the relatively small number of states in which we operate health plans;	

•	 	the availability of financing to fund and capitalize our acquisitions and start-up activities and to meet our liquidity needs;	

•	 	a state’s failure to renew its federal Medicaid waiver;	

•	 	an inadvertent unauthorized disclosure of protected health information;	

•	 	changes generally affecting the managed care or Medicaid management information systems industries;	

•	 	increases in government surcharges, taxes, and assessments; and	

•	 	changes in general economic conditions, including unemployment rates.	
Investors should refer to Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2010, for a discussion of certain risk factors that could materially affect our business, financial condition, cash flows, or results of operations. Given these risks and uncertainties, we can give no assurance that any results or events projected or contemplated by our forward-looking statements will in fact occur.
This document and the following discussion of our financial condition and results of operations should be read in conjunction with the accompanying consolidated financial statements and the notes to those statements appearing elsewhere in this report and the audited financial statements and Management’s Discussion and Analysis appearing in our Annual Report on Form 10-K for the year ended December 31, 2010.
Adjustments
We have adjusted all applicable share and per-share amounts to reflect the retroactive effects of the three-for-two stock split in the form of a stock dividend that was effective May 20, 2011.
Overview
Molina Healthcare, Inc. provides quality and cost-effective Medicaid-related solutions to meet the health care needs of low-income families and individuals, and to assist state agencies in their administration of the Medicaid program. Our business comprises our Health Plans segment, consisting of licensed health maintenance organizations serving Medicaid populations in ten states, and our Molina Medicaid Solutions segment, which provides design, development, implementation, and business process outsourcing solutions to Medicaid agencies in an additional five states. We also have a direct delivery business that currently consists of 14 primary care community clinics in California and two primary care community clinics in Washington; additionally, we manage three county-owned primary care clinics under a contract with Fairfax County, Virginia.
We report our financial performance based on the following two reportable segments: Health Plans; and Molina Medicaid Solutions.

23

Table of Contents
Our Health Plans segment comprises health plans in California, Florida, Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin. These health plans served approximately 1.6 million members eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals as of June 30, 2011. The health plans are operated by our respective wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization, or HMO.
On May 1, 2010, we acquired a health information management business which we now operate under the name, Molina Medicaid Solutions SM. Our Molina Medicaid Solutions segment provides design, development, implementation, and business process outsourcing solutions to state governments for their Medicaid Management Information Systems, or MMIS. MMIS is a core tool used to support the administration of state Medicaid and other health care entitlement programs. Molina Medicaid Solutions currently holds MMIS contracts with the states of Idaho, Louisiana, Maine, New Jersey, and West Virginia, as well as a contract to provide drug rebate administration services for the Florida Medicaid program.
Composition of Revenue and Membership
Health Plans Segment
Our Health Plans segment derives its revenue, in the form of premiums, chiefly from Medicaid contracts with the states in which our health plans operate. Premium revenue is fixed in advance of the periods covered and, except as described in “Critical Accounting Policies” below, is not generally subject to significant accounting estimates. For the six months ended June 30, 2011, we received approximately 94% of our premium revenue as a fixed amount per member per month, or PMPM, pursuant to our Medicaid contracts with state agencies, our Medicare contracts with the Centers for Medicare and Medicaid Services, or CMS, and our contracts with other managed care organizations for which we operate as a subcontractor. These premium revenues are recognized in the month that members are entitled to receive health care services. The state Medicaid programs and the federal Medicare program periodically adjust premium rates.
For the six months ended June 30, 2011, we received approximately 6% of our premium revenue in the form of “birth income” — a one-time payment for the delivery of a child — from the Medicaid programs in all of our state health plans except New Mexico. Such payments are recognized as revenue in the month the birth occurs.
The amount of the premiums paid to us may vary substantially between states and among various government programs. PMPM premiums for the Children’s Health Insurance Program, or CHIP, members are generally among our lowest, with rates as low as approximately $75 PMPM in California. Premium revenues for Medicaid members are generally higher. Among the Temporary Assistance for Needy Families, or TANF, Medicaid population — the Medicaid group that includes mostly mothers and children — PMPM premiums range between approximately $100 in California to $240 in Missouri. Among our Medicaid Aged, Blind or Disabled, or ABD, membership, PMPM premiums range from approximately $320 in Utah to $1,000 in Ohio. Contributing to the variability in Medicaid rates among the states is the practice of some states to exclude certain benefits from the managed care contract (most often pharmacy, inpatient and catastrophic case benefits) and retain responsibility for those benefits at the state level. Medicare membership generates the highest PMPM premiums, at nearly $1,200 PMPM.
The following table sets forth the approximate total number of members by state health plan as of the dates indicated:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	June 30,	 	 	March 31,	 	 	December 31,	 	 	June 30,	 	
 	 	2011	 	 	2011	 	 	2010	 	 	2010	 	
Total Ending Membership by Health Plan:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
California	 	 	348,000	 	 	 	347,000	 	 	 	344,000	 	 	 	348,000	 	
Florida	 	 	66,000	 	 	 	66,000	 	 	 	61,000	 	 	 	54,000	 	
Michigan	 	 	220,000	 	 	 	225,000	 	 	 	227,000	 	 	 	226,000	 	
Missouri	 	 	80,000	 	 	 	82,000	 	 	 	81,000	 	 	 	78,000	 	
New Mexico	 	 	89,000	 	 	 	90,000	 	 	 	91,000	 	 	 	93,000	 	
Ohio	 	 	245,000	 	 	 	248,000	 	 	 	245,000	 	 	 	234,000	 	
Texas	 	 	129,000	 	 	 	128,000	 	 	 	94,000	 	 	 	42,000	 	
Utah	 	 	82,000	 	 	 	80,000	 	 	 	79,000	 	 	 	77,000	 	
Washington	 	 	345,000	 	 	 	341,000	 	 	 	355,000	 	 	 	346,000	 	
Wisconsin (1)	 	 	41,000	 	 	 	40,000	 	 	 	36,000	 	 	 	—	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	 	1,645,000	 	 	 	1,647,000	 	 	 	1,613,000	 	 	 	1,498,000	 	

24

Table of Contents
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	June 30,	 	 	March 31,	 	 	December 31,	 	 	June 30,	 	
 	 	2011	 	 	2011	 	 	2010	 	 	2010	 	
Total Ending Membership by State for our Medicare Advantage Plans (1):	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
California	 	 	6,000	 	 	 	5,300	 	 	 	4,900	 	 	 	3,600	 	
Florida	 	 	600	 	 	 	600	 	 	 	500	 	 	 	500	 	
Michigan	 	 	7,100	 	 	 	6,700	 	 	 	6,300	 	 	 	5,000	 	
New Mexico	 	 	700	 	 	 	700	 	 	 	600	 	 	 	600	 	
Ohio	 	 	200	 	 	 	400	 	 	 	—	 	 	 	—	 	
Texas	 	 	600	 	 	 	600	 	 	 	700	 	 	 	600	 	
Utah	 	 	7,000	 	 	 	6,700	 	 	 	8,900	 	 	 	8,100	 	
Washington	 	 	4,000	 	 	 	3,300	 	 	 	2,600	 	 	 	1,900	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	 	26,200	 	 	 	24,300	 	 	 	24,500	 	 	 	20,300	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total Ending Membership by State for our Aged, Blind or Disabled Population:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
California	 	 	17,000	 	 	 	14,100	 	 	 	13,900	 	 	 	13,600	 	
Florida	 	 	10,300	 	 	 	10,300	 	 	 	10,000	 	 	 	9,300	 	
Michigan	 	 	31,600	 	 	 	32,000	 	 	 	31,700	 	 	 	31,600	 	
New Mexico	 	 	5,600	 	 	 	5,600	 	 	 	5,700	 	 	 	5,800	 	
Ohio	 	 	28,700	 	 	 	28,200	 	 	 	28,200	 	 	 	27,400	 	
Texas	 	 	52,000	 	 	 	51,200	 	 	 	19,000	 	 	 	18,500	 	
Utah	 	 	8,300	 	 	 	8,200	 	 	 	8,000	 	 	 	7,600	 	
Washington	 	 	4,400	 	 	 	4,300	 	 	 	4,000	 	 	 	3,700	 	
Wisconsin (1)	 	 	1,700	 	 	 	1,700	 	 	 	1,700	 	 	 	—	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	 	159,600	 	 	 	155,600	 	 	 	122,200	 	 	 	117,500	 	

 	 	 	
(1)	 	We acquired the Wisconsin health plan on September 1, 2010. As of June 30, 2011, the Wisconsin health plan had approximately 2,300 Medicare Advantage members covered under a reinsurance contract with a third party; these members are not included in the membership tables herein.	
Molina Medicaid Solutions Segment
Molina Medicaid Solutions’ MMIS contracts extend over a number of years, and cover the life of the MMIS from inception through at least the first five years of its operation. The contracts are subject to extension by the exercise of an option, and also by renewal of the base contract. The contracts have a life cycle beginning with the design, development, and implementation of the MMIS and continuing through the operation of the system. Payment during the design, development, and implementation phase of the contract, or the DDI phase, is generally based upon the attainment of specific milestones in systems development as agreed upon ahead of time by the parties. Payment during the operations phase typically takes the form of either a flat monthly fee or payment for specific measures of capacity or activity, such as the number of claims processed, or the number of Medicaid beneficiaries served by the MMIS. Contracts may also call for the adjustment of amounts paid if certain activity measures exceed or fall below certain thresholds. In some circumstances, revenue recognition may be delayed for long periods while we await formal customer acceptance of our products and/or services. In those circumstances, recognition of a portion of our costs may be deferred.
Under our contracts in Louisiana, New Jersey, and West Virginia, we provide primarily business process outsourcing and technology outsourcing services, because the development of the MMIS solution has been completed. Under these contracts, we recognize outsourcing service revenue on a straight-line basis over the remaining term of the contract. In Maine we completed the DDI phase of our contract effective September 1, 2010. In Idaho, we expect to complete the DDI phase of our contract during 2011. We began revenue and cost recognition for our Maine contract in September 2010, and expect to begin revenue and cost recognition for our Idaho contract in the second half of 2012.

25

Table of Contents
Composition of Expenses
Health Plans Segment
Operating expenses for the Health Plans segment include expenses related to the provision of medical care services, G&A expenses, and premium tax expenses. Our results of operations are impacted by our ability to effectively manage expenses related to medical care services and to accurately estimate medical costs incurred. Expenses related to medical care services are captured in the following four categories:
 	•	 	Fee-for-service — Expenses paid for specific encounters or episodes of care according to a fee schedule or other basis established by the state or by contract with the provider.	

 	•	 	Capitation — Expenses for PMPM payments to the provider without regard to the frequency, extent, or nature of the medical services actually furnished.	

 	•	 	Pharmacy — Expenses for all drug, injectible, and immunization costs paid through our pharmacy benefit manager.	

 	•	 	Other — Expenses for medically related administrative costs of approximately $49.6 million, and $41.0 million, for the six months ended June 30, 2011 and 2010, respectively, including certain provider incentive costs, reinsurance, costs to operate our medical clinics, and other medical expenses.	
Our medical care costs include amounts that have been paid by us through the reporting date as well as estimated liabilities for medical care costs incurred but not paid by us as of the reporting date. See “Critical Accounting Policies” below for a comprehensive discussion of how we estimate such liabilities.
Molina Medicaid Solutions Segment
Cost of service revenue consists primarily of the costs incurred to provide business process outsourcing and technology outsourcing services under our contracts in Louisiana, Maine, New Jersey, West Virginia, and Florida, as well as certain selling, general and administrative expenses. Additionally, certain indirect costs incurred under our contracts in Maine (prior to exiting the DDI phase of that contract in September 2010) and Idaho are also expensed to cost of service revenue.
In some circumstances we may defer recognition of incremental direct costs (such as direct labor, hardware, and software) associated with a contract if revenue recognition is also deferred. Such deferred contract costs are amortized on a straight-line basis over the remaining original contract term, consistent with the revenue recognition period. We began to recognize deferred costs for our Maine contract in September 2010, at the same time we began to recognize revenue associated with that contract. In Idaho, we expect to begin recognition of deferred contract costs in the second half of 2012, in a manner consistent with our anticipated recognition of revenue.
Second Quarter Performance Summary
The following table and narrative briefly summarizes our financial and operating performance for the three and six months ended June 30, 2011. Comparable metrics for the second quarter of 2010 are also shown. All ratios, with the exception of the medical care ratio and the premium tax ratio, are shown as a percentage of total revenue. The medical care ratio and the premium tax ratio are computed as a percentage of premium revenue because there are direct relationships between premium revenue earned, and the cost of health care and premium taxes.

26

Table of Contents
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	 	Six Months Ended	 	
 	 	June 30,	 	 	June 30,	 	
 	 	2011	 	 	2010	 	 	2011	 	 	2010	 	
 	 	(Dollar amounts in thousands, except per share data)	 	
Earnings per diluted share	 	$	0.38	 	 	$	0.27	 	 	$	0.75	 	 	$	0.54	 	
Premium revenue	 	$	1,128,770	 	 	$	976,685	 	 	$	2,210,208	 	 	$	1,941,905	 	
Service revenue	 	$	36,888	 	 	$	21,054	 	 	$	73,562	 	 	$	21,054	 	
Operating income	 	$	31,410	 	 	$	21,178	 	 	$	62,710	 	 	$	41,616	 	
Net income	 	$	17,440	 	 	$	10,579	 	 	$	34,828	 	 	$	21,169	 	
Total ending membership	 	 	1,645,000	 	 	 	1,498,000	 	 	 	1,645,000	 	 	 	1,498,000	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Premium revenue	 	 	96.7	%	 	 	97.7	%	 	 	96.7	%	 	 	98.8	%	
Service revenue	 	 	3.2	 	 	 	2.1	 	 	 	3.2	 	 	 	1.1	 	
Investment income	 	 	0.1	 	 	 	0.2	 	 	 	0.1	 	 	 	0.1	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total revenue	 	 	100.0	%	 	 	100.0	%	 	 	100.0	%	 	 	100.0	%	

Medical care ratio	 	 	84.1	%	 	 	86.0	%	 	 	84.3	%	 	 	85.6	%	
General and administrative expense ratio	 	 	8.3	%	 	 	7.8	%	 	 	8.4	%	 	 	8.0	%	
Premium tax ratio	 	 	3.3	%	 	 	3.6	%	 	 	3.4	%	 	 	3.6	%	
Operating income	 	 	2.7	%	 	 	2.1	%	 	 	2.7	%	 	 	2.1	%	
Net income	 	 	1.5	%	 	 	1.1	%	 	 	1.5	%	 	 	1.1	%	
Effective tax rate	 	 	37.1	%	 	 	38.1	%	 	 	37.2	%	 	 	38.0	%	
Compared with the second quarter of 2010, our second quarter of 2011 was marked by strong membership growth, increased PMPM revenue, and lower medical costs. Earnings per share in the second quarter of 2011 were up 41%, over the second quarter of 2010, premium revenues were up 16%, operating income was up 48%, and aggregate membership grew by 10%. Meanwhile, the aggregate medical care ratio of our health plans declined by 190 basis points. Our larger and more established health plans performed the strongest in the quarter, with each of California, Michigan, Ohio, Utah, and Washington having lower medical care ratios compared with the second quarter of 2010. Our Florida and Wisconsin health plans continue to face challenges, and our Texas health plan also experienced an increase in its medical care ratio in the second quarter. We have undertaken a number of measures—focused on both utilization and unit cost reductions—to improve the profitability of our Florida, Wisconsin, and Texas health plans. Our previous experiences in entering new states and in serving new populations —where we were able over time to reduce initially high medical care ratios—gives us confidence that we have the ability to improve the performance of our Florida, Wisconsin, and Texas health plans.
Medicare enrollment exceeded 26,000 members at June 30, 2011, and Medicare premium revenue for the quarter was $95.5 million compared with $67.6 million in the second quarter of 2010. With respect to our Molina Medicaid Solutions business, our system stabilization efforts in Idaho and Maine are taking longer and are more costly than we had anticipated. However, our profit margins in our fiscal agent contracts in New Jersey, Louisiana, and West Virginia remain stable, and we believe that the profitability of the Molina Medicaid Solutions segment will improve as system development and stabilization costs in Idaho and Maine decline.
We remain concerned about state budget deficits, which are not expected to improve during the remainder of 2011. Accordingly, the rate environment for our health plans remains uncertain, and in some instances we expect rate reductions during the second half of 2011, including a 2.5% reduction in New Mexico effective July 1, 2011, a 2% reduction in Utah effective July 1, 2011, and a modest rate reduction in Texas expected to be effective September 1, 2011. We also believe that the state of California intends to implement a rate reduction in the second half of 2011. However, our Missouri health plan has received notification that it will receive a blended rate increase of approximately 5% effective July 1, 2011.
On June 9, 2011, Molina Medicaid Solutions received notice from the state of Louisiana that the state intends to award the contract for a replacement MMIS to another firm. We have submitted a protest in connection with this notice, and in response the state has issued a stay of the intent to award and all contract negotiations have ceased. Our revenue under the Louisiana MMIS contract from May 1, 2010, the date we acquired Molina Medicaid Solutions, through December 31, 2010, was approximately $32 million. For the six months ended June 30, 2011, our revenue under the Louisiana MMIS contract was $24 million. Until the replacement MMIS is designed, developed, and implemented by the vendor that ultimately enters into a contract with the state, we will continue to perform under the existing MMIS contract, a period which we expect to last at least two years.

27

Table of Contents
Results of Operations
Three Months Ended June 30, 2011 Compared with the Three Months Ended June 30, 2010
Health Plans Segment
Premium Revenue
In the three months ended June 30, 2011 compared with the three months ended June 30, 2010, premium revenue grew 16% due to membership and PMPM revenue increases of approximately 10% and 5%, respectively. Medicare premium revenue was $95.5 million for the three months ended June 30, 2011, compared with $67.6 million for the three months ended June 30, 2010.
Medical Care Costs
The following table provides the details of consolidated medical care costs for the periods indicated (dollars in thousands except PMPM amounts):
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended June 30,	 	
 	 	2011	 	 	2010	 	
 	 	 	 	 	 	 	 	 	 	% of	 	 	 	 	 	 	 	 	 	 	% of	 	
 	 	Amount	 	 	PMPM	 	 	Total	 	 	Amount	 	 	PMPM	 	 	Total	 	
Fee for service	 	$	695,551	 	 	$	140.80	 	 	 	73.2	%	 	$	594,960	 	 	$	132.95	 	 	 	70.9	%	
Capitation	 	 	125,958	 	 	 	25.50	 	 	 	13.2	 	 	 	136,764	 	 	 	30.56	 	 	 	16.3	 	
Pharmacy	 	 	87,870	 	 	 	17.79	 	 	 	9.4	 	 	 	75,170	 	 	 	16.80	 	 	 	8.9	 	
Other	 	 	39,980	 	 	 	8.09	 	 	 	4.2	 	 	 	32,719	 	 	 	7.31	 	 	 	3.9	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	$	949,359	 	 	$	192.18	 	 	 	100.0	%	 	$	839,613	 	 	$	187.62	 	 	 	100.0	%	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
The ratio of medical care costs to premium revenue (the medical care ratio, or MCR) decreased to 84.1% in the three months ended June 30, 2011, compared with 86.0% for the three months ended June 30, 2010. Total medical care costs increased less than 3% PMPM, and less than 2% PMPM excluding the Texas health plan.
 	•	 	Pharmacy costs increased approximately 6% PMPM.	

 	•	 	Capitation costs decreased approximately 17% PMPM, primarily due to the transition of members in Michigan and Washington into fee-for-service networks.	

 	•	 	Fee-for-service costs increased approximately 6% PMPM, partially due to the transition of members from capitated provider networks into fee-for-service networks.	
 	 	 	 	
 	•	 	Fee-for-service and capitation costs combined increased less than 2% PMPM.	

 	•	 	Hospital utilization decreased approximately 8%.	
The medical care ratio of the California health plan decreased to 84.5% in the three months ended June 30, 2011, from 85.1% in the three months ended June 30, 2010, as higher premium revenue PMPM more than offset increased pharmacy and fee-for-service costs. The California health plan added approximately 2,800 new Aged, Blind or Disabled, or ABD, members in June 2011 with an average premium revenue PMPM of approximately $450. We believe that the state of California intends to implement a rate reduction in the second half of 2011.
The medical care ratio of the Florida health plan increased to 97.0% in the three months ended June 30, 2011, from 94.4% in the three months ended June 30, 2010, primarily due to higher fee-for-service and capitation costs, which more than offset lower pharmacy costs. We have undertaken a number of measures — focused on both utilization and unit cost reductions — to improve the profitability of the Florida health plan.

28

Table of Contents
The medical care ratio of the Michigan health plan decreased to 78.7% in the three months ended June 30, 2011, from 86.6% in the three months ended June 30, 2010, due to lower fee-for-service and capitation costs. Revenue at the Michigan health plan was reduced by approximately $5.5 million during the second quarter of 2010 due to retroactive rate reductions implemented by the state. Absent those reductions, the Michigan health plan’s medical care ratio would have been approximately 83.7% for the three months ended June 30, 2010.
The medical care ratio of the Missouri health plan increased to 90.2% in the three months ended June 30, 2011, from 89.5% in the three months ended June 30, 2010, due to higher fee-for-service costs. The Missouri health plan received a premium rate increase of approximately 5% effective July 1, 2011.
The medical care ratio of the New Mexico health plan increased to 83.7% in the three months ended June 30, 2011, from 79.6% in the three months ended June 30, 2010, as lower fee-for-service costs failed to offset the impact of rate reductions. Additionally, premium revenues were reduced due to an increase—in the second half of 2010—in the minimum contractual amount the plan is required to spend on medical costs. The New Mexico health plan received a premium rate reduction of approximately 2.5% effective July 1, 2011.
The medical care ratio of the Ohio health plan decreased to 77.6% in the three months ended June 30, 2011, from 82.0% in the three months ended June 30, 2010, due to an increase in Medicaid premium PMPM of approximately 4.5% effective January 1, 2011 and modestly lower fee-for-service costs.
The medical care ratio of the Texas health plan increased to 95.0% in the three months ended June 30, 2011, from 90.0% in the three months ended June 30, 2010. Effective February 1, 2011, we added approximately 30,000 ABD Medicaid members in the Dallas-Fort Worth area, and effective September 1, 2010, we added approximately 54,000 members state-wide who are covered under the Children’s Health Insurance Program, or CHIP. Costs associated with our ABD contracts, particularly in the Dallas-Fort Worth region, are running substantially higher than in our other markets, due to both high utilization and high unit costs. We have undertaken a number of measures — focused on both utilization and unit cost reductions — to improve the profitability of the Texas health plan. We believe that the state of Texas intends to implement a modest rate reduction effective September 1, 2011.
The medical care ratio of the Utah health plan decreased to 75.4% in the three months ended June 30, 2011, from 93.9% in the three months ended June 30, 2010, primarily due to reduced fee-for-service costs and an increase in Medicaid premium PMPM of approximately 7% effective July 1, 2010. Lower fee-for-service costs were the result of both lower unit costs and lower utilization. During the second quarter of 2011 we settled certain claims we had made against the state regarding the savings share provision of our contract in effect from 2003 through June of 2009. Additionally, we recognized a liability for certain overpayments received from the state for the period 2003 through 2009. As a result of these developments, we recognized $6.9 million in premium revenue without any corresponding charge to expense during the second quarter of 2011. The Utah health plan received a premium rate reduction of approximately 2% effective July 1, 2011.
The medical care ratio of the Washington health plan increased to 84.8% in the three months ended June 30, 2011, from 83.1% in the three months ended June 30, 2010. Higher fee-for-service and pharmacy costs more than offset lower capitation costs.
The medical care ratio of the Wisconsin health plan (acquired September 1, 2010) was 80.8% in the three months ended June 30, 2011. The Wisconsin health plan recorded a premium deficiency reserve of $3.35 million in the first quarter of 2011. That premium deficiency reserve was reduced by $1.8 million in the second quarter. Absent the premium deficiency reserve reduction, the Wisconsin plan’s MCR would have been approximately 91% in the three months ended June 30, 2011. We have undertaken a number of measures — focused on both utilization and unit cost reductions — to improve the profitability of the Wisconsin health plan.

29

Table of Contents
Health Plans Segment Operating Data
The following table summarizes member months, premium revenue, medical care costs, medical care ratio, and premium taxes by health plan for the periods indicated (PMPM amounts are in whole dollars; member months and other dollar amounts are in thousands):
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended June 30, 2011	 	
 	 	Member	 	 	Premium Revenue	 	 	Medical Care Costs	 	 	Medical	 	 	Premium Tax	 	
 	 	Months(1)	 	 	Total	 	 	PMPM	 	 	Total	 	 	PMPM	 	 	Care Ratio	 	 	Expense	 	
California	 	 	1,043	 	 	$	139,097	 	 	$	133.35	 	 	$	117,511	 	 	$	112.66	 	 	 	84.5	%	 	$	1,921	 	
Florida	 	 	197	 	 	 	49,770	 	 	 	252.78	 	 	 	48,294	 	 	 	245.29	 	 	 	97.0	 	 	 	34	 	
Michigan	 	 	668	 	 	 	165,575	 	 	 	247.74	 	 	 	130,325	 	 	 	195.00	 	 	 	78.7	 	 	 	9,728	 	
Missouri	 	 	243	 	 	 	56,625	 	 	 	232.80	 	 	 	51,100	 	 	 	210.08	 	 	 	90.2	 	 	 	—	 	
New Mexico	 	 	270	 	 	 	81,973	 	 	 	304.29	 	 	 	68,579	 	 	 	254.57	 	 	 	83.7	 	 	 	2,423	 	
Ohio	 	 	736	 	 	 	230,874	 	 	 	313.36	 	 	 	179,102	 	 	 	243.09	 	 	 	77.6	 	 	 	17,782	 	
Texas	 	 	391	 	 	 	104,399	 	 	 	267.06	 	 	 	99,154	 	 	 	253.64	 	 	 	95.0	 	 	 	2,063	 	
Utah	 	 	244	 	 	 	77,507	 	 	 	318.32	 	 	 	58,473	 	 	 	240.15	 	 	 	75.4	 	 	 	—	 	
Washington	 	 	1,027	 	 	 	202,595	 	 	 	197.39	 	 	 	171,742	 	 	 	167.33	 	 	 	84.8	 	 	 	3,662	 	
Wisconsin(2)	 	 	121	 	 	 	17,840	 	 	 	147.02	 	 	 	14,415	 	 	 	118.79	 	 	 	80.8	 	 	 	44	 	
Other(3)	 	 	—	 	 	 	2,515	 	 	 	—	 	 	 	10,664	 	 	 	—	 	 	 	—	 	 	 	52	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	4,940	 	 	$	1,128,770	 	 	$	228.50	 	 	$	949,359	 	 	$	192.18	 	 	 	84.1	%	 	$	37,709	 	

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended June 30, 2010	 	
 	 	Member	 	 	Premium Revenue	 	 	Medical Care Costs	 	 	Medical	 	 	Premium Tax	 	
 	 	Months(1)	 	 	Total	 	 	PMPM	 	 	Total	 	 	PMPM	 	 	Care Ratio	 	 	Expense	 	
California	 	 	1,050	 	 	$	124,551	 	 	$	118.57	 	 	$	106,006	 	 	$	100.92	 	 	 	85.1	%	 	$	1,637	 	
Florida	 	 	160	 	 	 	41,462	 	 	 	260.32	 	 	 	39,134	 	 	 	245.70	 	 	 	94.4	 	 	 	6	 	
Michigan	 	 	679	 	 	 	156,769	 	 	 	230.76	 	 	 	135,763	 	 	 	199.84	 	 	 	86.6	 	 	 	9,711	 	
Missouri	 	 	234	 	 	 	51,779	 	 	 	220.86	 	 	 	46,320	 	 	 	197.58	 	 	 	89.5	 	 	 	—	 	
New Mexico	 	 	280	 	 	 	91,949	 	 	 	328.48	 	 	 	73,210	 	 	 	261.54	 	 	 	79.6	 	 	 	2,987	 	
Ohio	 	 	695	 	 	 	212,669	 	 	 	306.34	 	 	 	174,275	 	 	 	251.03	 	 	 	82.0	 	 	 	16,512	 	
Texas	 	 	125	 	 	 	43,493	 	 	 	348.45	 	 	 	39,133	 	 	 	313.52	 	 	 	90.0	 	 	 	705	 	
Utah	 	 	230	 	 	 	64,934	 	 	 	281.44	 	 	 	60,975	 	 	 	264.28	 	 	 	93.9	 	 	 	—	 	
Washington	 	 	1,022	 	 	 	186,204	 	 	 	182.23	 	 	 	154,792	 	 	 	151.49	 	 	 	83.1	 	 	 	3,394	 	
Wisconsin(2)	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	
Other(3)	 	 	—	 	 	 	2,875	 	 	 	—	 	 	 	10,005	 	 	 	—	 	 	 	—	 	 	 	43	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	4,475	 	 	$	976,685	 	 	$	218.25	 	 	$	839,613	 	 	$	187.62	 	 	 	86.0	%	 	$	34,995	 	

 	 	 	
(1)	 	A member month is defined as the aggregate of each month’s ending membership for the period presented.	
 	 	 	
(2)	 	We acquired the Wisconsin health plan on September 1, 2010.	
 	 	 	
(3)	 	“Other” medical care costs also include medically related administrative costs at the parent company.	
Days in Medical Claims and Benefits Payable
The days in medical claims and benefits payable were as follows:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	June 30,	 	 	March 31,	 	 	Dec. 31,	 	 	June 30,	 	
(Dollars in thousands)	 	2011 	 	 	2011 	 	 	2010 	 	 	2010 	 	
Days in claims payable — fee-for-service only	 	39 days	 	41 days	 	42 days	 	44 days	
Number of claims in inventory at end of period	 	 	121,900	 	 	 	185,300	 	 	 	143,600	 	 	 	106,700	 	
Billed charges of claims in inventory at end of period (dollars in thousands)	 	$	205,800	 	 	$	250,600	 	 	$	218,900	 	 	$	147,500	 	
Molina Medicaid Solutions Segment
Molina Medicaid Solutions was acquired on May 1, 2010; therefore, the three months ended June 30, 2010 include only two months of operating results for this segment. Performance of the Molina Medicaid Solutions segment was as follows:
 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	 	Two Months Ended	 	
 	 	June 30, 2011	 	 	June 30, 2010	 	
 	 	(In thousands)	 	
Service revenue before amortization	 	$	38,434	 	 	$	22,645	 	
Less: amortization recorded as reduction of service revenue	 	 	(1,546	)	 	 	(1,591	)	
 	 	 	 	 	 	 	
Service revenue	 	 	36,888	 	 	 	21,054	 	
Cost of service revenue	 	 	39,215	 	 	 	14,254	 	
General and administrative costs	 	 	1,875	 	 	 	966	 	
Amortization of customer relationship intangibles recorded as amortization	 	 	1,282	 	 	 	829	 	
 	 	 	 	 	 	 	
Operating (loss) income	 	$	(5,484	)	 	$	5,005	 	

30

Table of Contents
In late April of 2011, Idaho Department of Health and Welfare indicated that it wished to remit to us an amount approximately $5 to $6 million less than the amount of our invoices for the operation of the MMIS in that state for the period June 1, 2010 through December 31, 2010. The Department claimed at that time that we were not in compliance with certain contractual requirements during the period June 1, 2010 through December 31, 2010. We do not believe the basis of the proposed reduction was contractually sound. In June 2011, we reached tentative agreement with the Department regarding the determination of our monthly operating revenue in Idaho. As a result of the tentative agreement, we estimate that revenue from operations in Idaho will be reduced by approximately $3 million for the period June 1, 2010 through June 30, 2011, and by an additional $1 million for the period July 1, 2011 through December 31, 2011. We do not believe that the tentative agreement will result in any reduction to amounts previously expected to be received for operations subsequent to December 31, 2011.
We are currently deferring recognition of all revenue as well as all direct costs (to the extent that such costs are estimated to be recoverable) in Idaho until the MMIS in that state receives certification from the Centers for Medicare and Medicaid Services. Cost of service revenue for the second quarter of 2011 includes $7.0 million of direct costs associated with the Idaho contract that would otherwise have had been recorded as deferred contract costs. In assessing the recoverability of the deferred contract costs associated with the Idaho contract at June 30, 2011, we determined that these costs should be expensed as a period cost. The reduction in anticipated revenue discussed above, as well as higher expected costs over the term of the contract, have lowered the net amount that we expect to realize under the contract, requiring us to write down deferred contract costs.
Financial results remain strong under our Louisiana, New Jersey, and West Virginia MMIS contracts. Based upon our cost experience, we believe that the contract pricing agreed to by our predecessor under the Idaho and Maine MMIS contracts was inappropriately low. However, we believe that the profitability of the Molina Medicaid Solutions segment will improve as system development and stabilization costs in those two states decline.
A substantial milestone for the Idaho contract was reached in early July 2011, when we received notice from the Idaho Department of Health and Welfare that the exit of our MMIS from “pilot operations” and “user acceptance testing” had been approved, and that we may now invoice the state for certain payments associated with that approval.
Consolidated Expenses
General and Administrative Expenses
General and administrative, or G&A, expenses, were $96.9 million, or 8.3% of total revenue, for the three months ended June 30, 2011 compared with $78.1 million, or 7.8% of total revenue, for the three months ended June 30, 2010.
Premium Tax Expenses
Premium tax expense decreased to 3.3% of premium revenue, in the three months ended June 30, 2011, from 3.6% in the three months ended June 30, 2010, due to a shift in revenue to states with comparatively low premium tax rates.
Interest Expense
Interest expense decreased to $3.7 million for the three months ended June 30, 2011, from $4.1 million for the three months ended June 30, 2010. Interest expense includes non-cash interest expense relating to our convertible senior notes, which totalled $1.4 million and $1.3 million for the three months ended June 30, 2011, and 2010, respectively.
Income Taxes
Income tax expense is recorded at an effective rate of 37.1% for the three months ended June 30, 2011 compared with 38.1% for the three months ended June 30, 2010. The lower rate in 2011 is primarily due to lower state income taxes.
Six Months Ended June 30, 2011 Compared with the Six Months Ended June 30, 2010
Health Plans Segment
Premium Revenue
Premium revenue grew 14% in the six months ended June 30, 2011, compared with the six months ended June 30, 2010, due to membership and PMPM revenue increases of 10% and 3%, respectively. Medicare premium revenue was $180.8 million for the six months ended June 30, 2011, compared with $117.9 million for the six months ended June 30, 2010.

31

Table of Contents
Medical Care Costs
The following table provides the details of consolidated medical care costs for the periods indicated (dollars in thousands except PMPM amounts):
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Six Months Ended June 30,	 	
 	 	2011	 	 	2010	 	
 	 	 	 	 	 	 	 	 	 	% of	 	 	 	 	 	 	 	 	 	 	% of	 	
 	 	Amount	 	 	PMPM	 	 	Total	 	 	Amount	 	 	PMPM	 	 	Total	 	
Fee for service	 	$	1,351,435	 	 	$	137.31	 	 	 	72.5	%	 	$	1,161,839	 	 	$	130.52	 	 	 	69.9	%	
Capitation	 	 	254,640	 	 	 	25.87	 	 	 	13.7	 	 	 	273,896	 	 	 	30.77	 	 	 	16.5	 	
Pharmacy	 	 	179,446	 	 	 	18.23	 	 	 	9.6	 	 	 	165,241	 	 	 	18.56	 	 	 	9.9	 	
Other	 	 	77,370	 	 	 	7.86	 	 	 	4.2	 	 	 	61,453	 	 	 	6.90	 	 	 	3.7	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	$	1,862,891	 	 	$	189.27	 	 	 	100.0	%	 	$	1,662,429	 	 	$	186.75	 	 	 	100.0	%	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
The medical care ratio decreased to 84.3% in the six months ended June 30, 2011, compared with 85.6% for the six months ended June 30, 2010. Total medical care costs increased less than 2% PMPM.
 	•	 	Pharmacy costs (adjusted for the state’s retention of the pharmacy benefit in Ohio effective February 1, 2010) increased approximately 5% PMPM.	

 	•	 	Capitation costs decreased approximately 16% PMPM, primarily due to the transition of members in Michigan and Washington into fee-for-service networks.	

 	•	 	Fee-for-service costs increased approximately 5% PMPM, partially due to the transition of members from capitated provider networks into fee-for-service networks.	

 	•	 	Fee-for-service and capitation costs combined increased approximately 1% PMPM.	

 	•	 	Hospital utilization decreased approximately 7%.	
The medical care ratio of the California health plan decreased to 84.4% in the six months ended June 30, 2011, from 86.0% in the six months ended June 30, 2010, as higher premium revenue PMPM more than offset higher pharmacy and fee-for-service costs. We believe that the state of California intends to implement a rate reduction in the second half of 2011.
The medical care ratio of the Florida health plan increased to 96.8% in the six months ended June 30, 2011, from 91.7% in the six months ended June 30, 2010, primarily due to higher fee-for-service and capitation costs, which more than offset lower pharmacy costs. We have undertaken a number of measures — focused on both utilization and unit cost reductions — to improve the profitability of the Florida health plan.
The medical care ratio of the Michigan health plan decreased to 79.9% in the six months ended June 30, 2011, from 83.7% in the six months ended June 30, 2010 as lower pharmacy and capitation costs more than offset increased fee-for-service costs. As discussed above, the medical care ratio for the Michigan health plan was increased in the first half of 2011 by retroactive rate reductions implemented by the state. The total impact of those reductions was to decrease premium revenue by $8.7 million in the first half of 2010. Absent those reductions, the Michigan health plan’s medical ratio would have been approximately 81.4% for the six months ended June 30, 2010.
The medical care ratio of the Missouri health plan increased to 91.9% in the six months ended June 30, 2011, from 86.5% in the six months ended June 30, 2010, due to higher fee-for-service costs. As noted above, the Missouri health plan received a premium rate increase of approximately 5% effective July 1, 2011.

32

Table of Contents
The medical care ratio of the New Mexico health plan increased to 83.2% in the six months ended June 30, 2011, from 78.5% in the six months ended June 30, 2010, as lower fee-for-service costs failed to offset the impact of rate reductions. Additionally, premium revenues were reduced due to an increase—in the second half of 2010—in the minimum contractual amount the plan is required to spend on medical costs. The New Mexico health plan received a premium rate reduction of approximately 2.5% effective July 1, 2011.
The medical care ratio of the Ohio health plan decreased to 76.1% in the six months ended June 30, 2011, from 80.5% in the six months ended June 30, 2010, due to an increase in Medicaid premium PMPM of approximately 4.5% effective January 1, 2011 and modestly lower fee-for-service costs.
The medical care ratio of the Texas health plan increased to 93.3% in the six months ended June 30, 2011, from 86.4% in the six months ended June 30, 2010. Effective February 1, 2011, we added approximately 30,000 ABD Medicaid members in the Dallas-Fort Worth area, and effective September 1, 2010, we added approximately 54,000 members state-wide who are covered under CHIP. Costs associated with our ABD contracts, particularly in the Dallas-Fort Worth region, are running substantially higher than in our other markets, due to both high utilization and high unit costs. We have undertaken a number of measures — focused on both utilization and unit cost reductions — to improve the profitability of the Texas health plan. We believe that the state of Texas intends to implement a modest rate reduction effective September 1, 2011.
The medical care ratio of the Utah health plan decreased to 77.2% in the six months ended June 30, 2011, from 99.2% in the six months ended June 30, 2010, primarily due to reduced fee-for-service outpatient and physician costs and an increase in Medicaid premium PMPM of approximately 7% effective July 1, 2010. Lower fee-for-service costs were the result of both lower unit costs and lower utilization. During the second quarter we settled certain claims with the state regarding the savings share provision of our contract in effect from 2003 through June of 2009. We settled for the contract years 2006 through 2009 and recognized $6.9 million in premium revenue without any corresponding charge to expense. The Utah health plan received a premium rate reduction of approximately 2% effective July 1, 2011.
The medical care ratio of the Washington health plan decreased to 85.7% in the six months ended June 30, 2011, from 86.7% in the six months ended June 30, 2010. Lower capitation costs more than offset higher fee-for-service and higher pharmacy costs.
The medical care ratio of the Wisconsin health plan (acquired September 1, 2010) was 98.7% in the six months ended June 30, 2011. We have undertaken a number of measures — focused on both utilization and unit cost reductions — to improve the profitability of the Wisconsin health plan.
Health Plans Segment Operating Data
The following table summarizes member months, premium revenue, medical care costs, medical care ratio, and premium taxes by health plan for the periods indicated (PMPM amounts are in whole dollars; member months and other dollar amounts are in thousands):
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Six Months Ended June 30, 2011	 	
 	 	Member	 	 	Premium Revenue	 	 	Medical Care Costs	 	 	Medical	 	 	Premium Tax	 	
 	 	Months(1)	 	 	Total	 	 	PMPM	 	 	Total	 	 	PMPM	 	 	Care Ratio	 	 	Expense	 	
California	 	 	2,084	 	 	$	274,073	 	 	$	131.49	 	 	$	231,248	 	 	$	110.95	 	 	 	84.4	%	 	$	3,823	 	
Florida	 	 	389	 	 	 	98,992	 	 	 	254.68	 	 	 	95,863	 	 	 	246.63	 	 	 	96.8	 	 	 	51	 	
Michigan	 	 	1,346	 	 	 	330,335	 	 	 	245.38	 	 	 	264,053	 	 	 	196.15	 	 	 	79.9	 	 	 	19,575	 	
Missouri	 	 	488	 	 	 	111,792	 	 	 	229.05	 	 	 	102,707	 	 	 	210.44	 	 	 	91.9	 	 	 	—	 	
New Mexico	 	 	541	 	 	 	166,579	 	 	 	308.12	 	 	 	138,616	 	 	 	256.40	 	 	 	83.2	 	 	 	4,388	 	
Ohio	 	 	1,473	 	 	 	461,213	 	 	 	313.02	 	 	 	350,853	 	 	 	238.12	 	 	 	76.1	 	 	 	35,557	 	
Texas	 	 	740	 	 	 	185,210	 	 	 	250.28	 	 	 	172,769	 	 	 	233.47	 	 	 	93.3	 	 	 	3,403	 	
Utah	 	 	480	 	 	 	145,442	 	 	 	303.28	 	 	 	112,312	 	 	 	234.20	 	 	 	77.2	 	 	 	—	 	
Washington	 	 	2,061	 	 	 	397,867	 	 	 	193.09	 	 	 	340,857	 	 	 	165.42	 	 	 	85.7	 	 	 	7,323	 	
Wisconsin(2)	 	 	241	 	 	 	34,257	 	 	 	142.17	 	 	 	33,794	 	 	 	140.25	 	 	 	98.7	 	 	 	44	 	
Other(3)	 	 	—	 	 	 	4,448	 	 	 	—	 	 	 	19,819	 	 	 	—	 	 	 	—	 	 	 	95	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	9,843	 	 	$	2,210,208	 	 	$	224.56	 	 	$	1,862,891	 	 	$	189.27	 	 	 	84.3	%	 	$	74,259	 	

33

Table of Contents
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Six Months Ended June 30, 2010	 	
 	 	Member	 	 	Premium Revenue	 	 	Medical Care Costs	 	 	Medical	 	 	Premium Tax	 	
 	 	Months(1)	 	 	Total	 	 	PMPM	 	 	Total	 	 	PMPM	 	 	Care Ratio	 	 	Expense	 	
California	 	 	2,112	 	 	$	248,461	 	 	$	117.62	 	 	$	213,567	 	 	$	101.10	 	 	 	86.0	%	 	$	3,265	 	
Florida	 	 	314	 	 	 	80,550	 	 	 	256.94	 	 	 	73,821	 	 	 	235.47	 	 	 	91.7	 	 	 	12	 	
Michigan	 	 	1,354	 	 	 	312,114	 	 	 	230.45	 	 	 	261,212	 	 	 	192.87	 	 	 	83.7	 	 	 	19,650	 	
Missouri	 	 	468	 	 	 	103,922	 	 	 	221.93	 	 	 	89,836	 	 	 	191.85	 	 	 	86.5	 	 	 	—	 	
New Mexico	 	 	560	 	 	 	187,547	 	 	 	334.75	 	 	 	147,225	 	 	 	262.78	 	 	 	78.5	 	 	 	4,991	 	
Ohio	 	 	1,368	 	 	 	431,032	 	 	 	315.20	 	 	 	346,900	 	 	 	253.68	 	 	 	80.5	 	 	 	33,517	 	
Texas	 	 	246	 	 	 	82,693	 	 	 	336.46	 	 	 	71,464	 	 	 	290.77	 	 	 	86.4	 	 	 	1,386	 	
Utah	 	 	451	 	 	 	123,474	 	 	 	273.66	 	 	 	122,435	 	 	 	271.36	 	 	 	99.2	 	 	 	—	 	
Washington	 	 	2,029	 	 	 	367,258	 	 	 	181.05	 	 	 	318,302	 	 	 	156.91	 	 	 	86.7	 	 	 	6,656	 	
Wisconsin(2)	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	
Other(3)	 	 	—	 	 	 	4,854	 	 	 	—	 	 	 	17,667	 	 	 	—	 	 	 	—	 	 	 	64	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	8,902	 	 	$	1,941,905	 	 	$	218.15	 	 	$	1,662,429	 	 	$	186.75	 	 	 	85.6	%	 	$	69,541	 	

 	 	 	
(1)	 	A member month is defined as the aggregate of each month’s ending membership for the period presented.	
 	 	 	
(2)	 	We acquired the Wisconsin health plan on September 1, 2010.	
 	 	 	
(3)	 	“Other” medical care costs also include medically related administrative costs of the parent company.	
Molina Medicaid Solutions Segment
Molina Medicaid Solutions was acquired on May 1, 2010; therefore, the six months ended June 30, 2010 include only two months of operating results for this segment. Performance of the Molina Medicaid Solutions segment was as follows:
 	 	 	 	 	 	 	 	 	
 	 	Six Months Ended	 	 	Two Months Ended	 	
 	 	June 30, 2011	 	 	June 30, 2010	 	
 	 	(In thousands)	 	
Service revenue before amortization	 	$	77,294	 	 	$	22,645	 	
Amortization recorded as reduction of service revenue	 	 	(3,732	)	 	 	(1,591	)	
 	 	 	 	 	 	 	
Service revenue	 	 	73,562	 	 	 	21,054	 	
Cost of service revenue	 	 	70,436	 	 	 	14,254	 	
General and administrative costs	 	 	4,352	 	 	 	966	 	
Amortization of customer relationship intangibles recorded as amortization	 	 	2,564	 	 	 	829	 	
 	 	 	 	 	 	 	
Operating (loss) income	 	$	(3,790	)	 	$	5,005	 	
 	 	 	 	 	 	 	
Consolidated Expenses and Other
General and Administrative Expenses
General and administrative expenses were $191.4 million, or 8.4% of total revenue, for the six months ended June 30, 2011 compared with $157.0 million, or 8.0% of total revenue, for the six months ended June 30, 2010.
Premium Tax Expense
Premium tax expense decreased to 3.4% of premium revenue, in the six months ended June 30, 2011, from 3.6% in the six months ended June 30, 2010, due to a shift in revenue to states with comparatively low premium tax rates.

34

Table of Contents
Interest Expense
Interest expense decreased to $7.3 million for the six months ended June 30, 2011, from $7.5 million for the six months ended June 30, 2010. Interest expense includes non-cash interest expense relating to our convertible senior notes, which totalled $2.7 million, and $2.5 million for the six months ended June 30, 2011 and 2010, respectively.
Income Taxes
Income tax expense is recorded at an effective rate of 37.2% for the six months ended June 30, 2011 compared with 38.0% for the six months ended June 30, 2010. The lower rate in 2011 is primarily due to lower state income taxes.
Depreciation and Amortization
Depreciation and amortization related to our Health Plans segment is all recorded in “Depreciation and Amortization” in the consolidated statements of income. Depreciation and amortization related to our Molina Medicaid Solutions segment is recorded within three different headings in the consolidated statements of income as follows:
 	•	 	Amortization of purchased intangibles relating to customer relationships is reported as amortization within the heading “Depreciation and Amortization;”	

 	•	 	Amortization of purchased intangibles relating to contract backlog is recorded as a reduction of “Service Revenue;” and	

 	•	 	Depreciation is recorded within the heading “Cost of Service Revenue.”	
The following table presents all depreciation and amortization recorded in our consolidated statements of income, regardless of whether the item appears as depreciation and amortization, a reduction of revenue, or as cost of service revenue.
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended June 30,	 	
 	 	2011	 	 	2010	 	
 	 	 	 	 	 	% of Total	 	 	 	 	 	 	% of Total	 	
 	 	Amount	 	 	Revenue	 	 	Amount	 	 	Revenue	 	
 	 	(Dollar amounts in thousands)	 	
Depreciation	 	$	7,225	 	 	 	0.6	%	 	$	6,711	 	 	 	0.7	%	
Amortization of intangible assets	 	 	5,265	 	 	 	0.5	 	 	 	4,508	 	 	 	0.4	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Depreciation and amortization reported as such in the consolidated statements of income	 	 	12,490	 	 	 	1.1	 	 	 	11,219	 	 	 	1.1	 	
Amortization recorded as reduction of service revenue	 	 	1,546	 	 	 	0.1	 	 	 	1,591	 	 	 	0.2	 	
Depreciation recorded as cost of service revenue	 	 	2,472	 	 	 	0.2	 	 	 	1,041	 	 	 	0.1	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	$	16,508	 	 	 	1.4	%	 	$	13,851	 	 	 	1.4	%	

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Six Months Ended June 30,	 	
 	 	2011	 	 	2010	 	
 	 	 	 	 	 	% of Total	 	 	 	 	 	 	% of Total	 	
 	 	Amount	 	 	Revenue	 	 	Amount	 	 	Revenue	 	
 	 	(Dollar amounts in thousands)	 	
Depreciation	 	$	14,625	 	 	 	0.6	%	 	$	13,123	 	 	 	0.7	%	
Amortization of intangible assets	 	 	10,532	 	 	 	0.5	 	 	 	8,157	 	 	 	0.4	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Depreciation and amortization reported as such in the consolidated statements of income	 	 	25,157	 	 	 	1.1	 	 	 	21,280	 	 	 	1.1	 	
Amortization recorded as reduction of service revenue	 	 	3,732	 	 	 	0.2	 	 	 	1,591	 	 	 	0.1	 	
Depreciation recorded as cost of service revenue	 	 	5,713	 	 	 	0.2	 	 	 	1,041	 	 	 	—	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	$	34,602	 	 	 	1.5	%	 	$	23,912	 	 	 	1.2	%	

35

Table of Contents
Liquidity and Capital Resources
We manage our cash, investments, and capital structure to meet the short- and long-term obligations of our business while maintaining liquidity and financial flexibility. We forecast, analyze, and monitor our cash flows to enable prudent investment management and financing within the confines of our financial strategy.
Our regulated subsidiaries generate significant cash flows from premium revenue and investment income. Such cash flows are our primary source of liquidity. Thus, any future decline in our profitability may have a negative impact on our liquidity. We generally receive premium revenue in advance of the payment of claims for the related health care services. A majority of the assets held by our regulated subsidiaries are in the form of cash, cash equivalents, and investments. After considering expected cash flows from operating activities, we generally invest cash of regulated subsidiaries that exceeds our expected short-term obligations in longer term, investment-grade, marketable debt securities to improve our overall investment return. These investments are made pursuant to board approved investment policies which conform to applicable state laws and regulations. Our investment policies are designed to provide liquidity, preserve capital, and maximize total return on invested assets, all in a manner consistent with state requirements that prescribe the types of instruments in which our subsidiaries may invest. These investment policies require that our investments have final maturities of five years or less (excluding auction rate securities and variable rate securities, for which interest rates are periodically reset) and that the average maturity be two years or less. Professional portfolio managers operating under documented guidelines manage our investments. As of June 30, 2011, a substantial portion of our cash was invested in a portfolio of highly liquid money market securities, and our investments consisted solely of investment-grade debt securities. All of our investments are classified as current assets, except for our investments in auction rate securities, which are classified as non-current assets. Our restricted investments are invested principally in certificates of deposit and U.S. treasury securities.
Investment income decreased to $3.0 million for the six months ended June 30, 2011, compared with $3.1 million for the six months ended June 30, 2010. Our annualized portfolio yield for the six months ended June 30, 2011 was 0.7% compared with 0.9% for the six months ended June 30, 2010.
Investments and restricted investments are subject to interest rate risk and will decrease in value if market rates increase. We have the ability to hold our restricted investments until maturity and, as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Declines in interest rates over time will reduce our investment income.
Cash in excess of the capital needs of our regulated health plans is generally paid to our non-regulated parent company in the form of dividends, when and as permitted by applicable regulations, for general corporate use.
Cash provided by operating activities for the six months ended June 30, 2011 was $114.9 million compared with $25.9 million for the six months ended June 30, 2010, an increase of $89.0 million. Deferred revenue, which was a source of operating cash totalling $69.5 million in 2011, was a use of operating cash totalling $82.7 million in 2010.
Cash provided by financing activities decreased due to $105 million borrowed under our credit facility in the second quarter of 2010 in connection with our acquisition of Molina Medicaid Solutions, with no comparable activity in the current year.

36

Table of Contents
Reconciliation of Non-GAAP (1) to GAAP Financial Measures
EBITDA(2)
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	 	Six Months Ended	 	
 	 	June 30,	 	 	June 30,	 	
 	 	2011	 	 	2010	 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
Operating income	 	$	31,410	 	 	$	21,178	 	 	$	62,710	 	 	$	41,616	 	
Add back:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Depreciation and amortization reported in the consolidated statements of cash flows	 	 	16,508	 	 	 	13,851	 	 	 	34,602	 	 	 	23,912	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
EBITDA	 	$	47,918	 	 	$	35,029	 	 	$	97,312	 	 	$	65,528	 	

 	 	 	
(1)	 	GAAP stands for U.S. generally accepted accounting principles.	
 	 	 	
(2)	 	We calculate EBITDA consistently on a quarterly and annual basis by adding back depreciation and amortization to operating income. Operating income includes investment income. EBITDA is not prepared in conformity with GAAP because it excludes depreciation and amortization, as well as interest expense, and the provision for income taxes. This non-GAAP financial measure should not be considered as an alternative to the GAAP measures of net income, operating income, operating margin, or cash provided by operating activities, nor should EBITDA be considered in isolation from these GAAP measures of operating performance. Management uses EBITDA as a supplemental metric in evaluating our financial performance, in evaluating financing and business development decisions, and in forecasting and analyzing future periods. For these reasons, management believes that EBITDA is a useful supplemental measure to investors in evaluating our performance and the performance of other companies in our industry.	
Capital Resources
At June 30, 2011, the parent company — Molina Healthcare, Inc. — held cash and investments of approximately $49.6 million, compared with approximately $65.1 million of cash and investments at December 31, 2010. This decline was primarily due to capital contributions and /or advances to our Florida, Texas, and Wisconsin health plans in the first quarter of 2011.
On a consolidated basis, at June 30, 2011, we had working capital of $419.3 million compared with $392.4 million at December 31, 2010. At June 30, 2011 we had cash and investments of $885.1 million, compared with $813.8 million of cash and investments at December 31, 2010.
We believe that our cash resources and internally generated funds will be sufficient to support our operations, regulatory requirements, and capital expenditures for at least the next 12 months.
Credit Facility
We are a party to an Amended and Restated Credit Agreement, dated as of March 9, 2005, as amended by the first amendment on October 5, 2005, the second amendment on November 6, 2006, the third amendment on May 25, 2008, the fourth amendment on April 29, 2010, and the fifth amendment on April 29, 2010, among Molina Healthcare Inc., certain lenders, and Bank of America N.A., as Administrative Agent (the “Credit Facility”) for a revolving credit line of $150 million that matures in May 2012. The Credit Facility is intended to be used for general corporate purposes. As of June 30, 2011, and December 31, 2010, there was no outstanding principal balance under the Credit Facility. However, as of June 30, 2011, our lenders had issued two letters of credit in the aggregate principal amount of $10.3 million in connection with the Molina Medicaid Solutions contracts with the states of Maine and Idaho.
To the extent that in the future we incur any obligations under the Credit Facility, such obligations will be secured by a lien on substantially all of our assets and by a pledge of the capital stock of our health plan subsidiaries (with the exception of the California health plan). The Credit Facility includes usual and customary covenants for credit facilities of this type, including covenants limiting liens, mergers, asset sales, other fundamental changes, debt, acquisitions, dividends and other distributions, capital expenditures, investments, and a fixed charge coverage ratio. The Credit Facility also requires us to maintain a ratio of total consolidated debt to total consolidated EBITDA of not more than 2.75 to 1.00 at any time. At June 30, 2011, we were in compliance with all financial covenants in the Credit Facility.

37

Table of Contents
The commitment fee on the total unused commitments of the lenders under the Credit Facility is 50 basis points on all levels of the pricing grid, with the pricing grid referring to our ratio of consolidated funded debt to consolidated EBITDA. The pricing for LIBOR loans and base rate loans is 200 basis points at every level of the pricing grid. Thus, the applicable margins under the Credit Facility range between 2.75% and 3.75% for LIBOR loans, and between 1.75% and 2.75% for base rate loans. The Credit Facility carves out from our indebtedness and restricted payment covenants under the Credit Facility the $187.0 million current principal amount of the convertible senior notes, although the $187.0 million indebtedness is included in the calculation of our consolidated leverage ratio. The fixed charge coverage ratio under the Credit Facility is required to be no less than 3.00x.
The fifth amendment increased the maximum consolidated leverage ratio under the Credit Facility to 3.50 to 1.0 for the first and second quarters of 2010 and through August 14, 2010 (on a pro forma basis). Effective as of August 15, 2010, the maximum consolidated leverage ratio under the Credit Facility reverted back to 2.75 to 1.0.
Shelf Registration Statement
Under a shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission in December 2008, we have up to $182.5 million available for the issuance of our securities, including common stock, warrants, or debt securities, that may be publicly offered from time to time at prices and terms to be determined at the time of the offering.
Convertible Senior Notes
As of June 30, 2011, $187.0 million in aggregate principal amount of our 3.75% Convertible Senior Notes due 2014 (the “Notes”) remain outstanding. The Notes rank equally in right of payment with our existing and future senior indebtedness. The Notes are convertible into cash and, under certain circumstances, shares of our common stock. The initial conversion rate is 31.9601 shares of our common stock per $1,000 principal amount of the Notes. This represents an initial conversion price of approximately $31.29 per share of our common stock. In addition, if certain corporate transactions that constitute a change of control occur prior to maturity, we will increase the conversion rate in certain circumstances.
Regulatory Capital and Dividend Restrictions
Our health plans are subject to state laws and regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent the subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. The net assets in these subsidiaries (after intercompany eliminations) which may not be transferable to us in the form of loans, advances, or cash dividends was $438.5 million at June 30, 2011, and $397.8 million at December 31, 2010.
The National Association of Insurance Commissioners, or NAIC, adopted rules effective December 31, 1998, which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for health care coverage. The requirements take the form of risk-based capital (RBC) rules. Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin have adopted these rules, which may vary from state to state. California and Florida have not yet adopted NAIC risk-based capital requirements for HMOs and have not formally given notice of their intention to do so. Such requirements, if adopted by California and Florida, may increase the minimum capital required for those states.
As of June 30, 2011, our health plans had aggregate statutory capital and surplus of approximately $448.0 million compared with the required minimum aggregate statutory capital and surplus of approximately $273.6 million. All of our health plans were in compliance with the minimum capital requirements at June 30, 2011. We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements.
Contractual Obligations
In our Annual Report on Form 10-K for the year ended December 31, 2010, we reported on our contractual obligations as of that date. There have been no material changes to our contractual obligations since that report.

38

Table of Contents
Critical Accounting Policies
When we prepare our consolidated financial statements, we use estimates and assumptions that may affect reported amounts and disclosures. Actual results could differ from these estimates. Our most significant accounting policies relate to:
 	•	 	The determination of the amount of revenue to be recognized under certain contracts that place revenue at risk dependent upon the achievement of certain quality or administrative measurements, or the expenditure of certain percentages of revenue on defined expenses, or requirements that we return a certain portion of our profits to state governments;	

 	•	 	The deferral of revenue and costs associated with contracts held by our Molina Medicaid Solutions segment; and	

 	•	 	The determination of medical claims and benefits payable.	
Revenue Recognition — Health Plans Segment
Certain components of premium revenue are subject to accounting estimates, and are therefore subject to retroactive revision. Chief among these are:
 	•	 	Florida Health Plan Medical Cost Floor (Minimum) for Behavioral Health: A portion of premium revenue paid to our Florida health plan by the state of Florida may be refunded to the state if certain minimum amounts are not spent on defined behavioral health care costs. At June 30, 2011, we had not recorded any liability under the terms of this contract provision. If the state of Florida disagrees with our interpretation of the existing contract terms, an adjustment to the amounts owed may be required. Any changes to the terms of this provision, including revisions to the definitions of premium revenue or behavioral health care costs, the period of time over which performance is measured or the manner of its measurement, or the percentages used in the calculations, may affect the profitability of our Florida health plan.	

 	•	 	New Mexico Health Plan Medical Cost Floors (Minimums) and Administrative Cost and Profit Ceilings (Maximums):  A portion of premium revenue paid to our New Mexico health plan by the state of New Mexico may be refunded to the state if certain minimum amounts are not spent on defined medical care costs, or if administrative costs or profit (as defined) exceed certain amounts. Our contract with the state of New Mexico requires that we spend a minimum percentage of premium revenue on certain explicitly defined medical care costs (the medical cost floor). Effective July 1, 2008, our New Mexico health plan entered into a new four-year contract that, in addition to retaining the medical cost floor, added certain limits on the amount our New Mexico health plan can: (a) expend on administrative costs; and (b) retain as profit. At June 30, 2011, we had recorded a liability of $12.1 million under the terms of these contract provisions. If the state of New Mexico disagrees with our interpretation of the existing contract terms, an adjustment to the amounts owed may be required. Any changes to the terms of these provisions, including revisions to the definitions of premium revenue, medical care costs, administrative costs or profit, the period of time over which performance is measured or the manner of its measurement, or the percentages used in the calculations, may affect the profitability of our New Mexico health plan.	

 	•	 	New Mexico Health Plan At-Risk Premium Revenue: Under our contract with the state of New Mexico, up to 1% of our New Mexico health plan’s revenue may be refundable to the state if certain performance measures are not met. These performance measures are generally linked to various quality of care and administrative measures dictated by the state. For the twelve months ended through the end of the state fiscal year on June 30, 2011, our New Mexico health plan has received $2.6 million in at-risk revenue for state fiscal year 2011. We have recognized $1.9 million of that amount as revenue, and recorded a liability of approximately $0.7 million as of June 30, 2011, for the remainder. If the state of New Mexico disagrees with our estimation of our compliance with the at-risk premium requirements, an adjustment to the amounts owed may be required.	

39

Table of Contents

 	•	 	Ohio Health Plan At-Risk Premium Revenue: Under our contract with the state of Ohio, up to 1% of our Ohio health plan’s revenue may be refundable to the state if certain performance measures are not met. Effective February 1, 2010, an additional 0.25% of the Ohio health plan’s revenue became refundable if certain pharmacy specific performance measures were not met. These performance measures are generally linked to various quality-of-care measures dictated by the state. For the twelve months ended through the end of the state fiscal year on June 30, 2011, our Ohio health plan has received $10.3 million in at-risk revenue for state fiscal year 2011. We have recognized $8.6 million of that amount as revenue, and recorded a liability of approximately $1.7 million as of June 30, 2011, for the remainder. If the state of Ohio disagrees with our estimation of our compliance with the at-risk premium requirements, an adjustment to the amounts owed may be required. For example, during the third quarter of 2010, we reversed the recognition of approximately $3.3 million of at-risk revenue, of which $1.9 million and $1.4 million were initially recognized in 2010, and 2009, respectively.	

 	•	 	Utah Health Plan Premium Revenue: Our Utah health plan was entitled to receive additional premium revenue from the state of Utah as an incentive payment for saving the state of Utah money in relation to fee-for-service Medicaid during the period 2003 through August 31, 2009.	

 	 	 	During the second quarter of 2011 we settled all claims related to state contract years 2006 through 2009 and received payments totalling $13.6 million in settlement of this matter. The state in turn has made demands upon us totalling $9.6 million to recover alleged over payment of premium revenue to us for the period 2003 through 2009. We are disputing many of those claims and have recorded a liability of approximately $6.7 million in connection with the premium revenue overpayments. We recognized approximately $6.9 million of revenue in connection with this matter during the second of quarter of 2011, without any corresponding increase to expense.	

 	•	 	Texas Health Plan Profit Sharing: Under our contract with the state of Texas there is a profit-sharing agreement, where we pay a rebate to the state of Texas if our Texas health plan generates pretax income, as defined in the contract, above a certain specified percentage, as determined in accordance with a tiered rebate schedule. We are limited in the amount of administrative costs that we may deduct in calculating the rebate, if any. As of June 30, 2011, we had an aggregate liability of approximately $0.1 million accrued pursuant to our profit-sharing agreement with the state of Texas for the 2010 and 2011 contract years (ending August 31st of each year). Because the final settlement calculations include a claims run-out period of nearly one year, an adjustment to the amounts owed may be required.	

40

Table of Contents

 	•	 	Texas Health Plan At-Risk Premium Revenue: Under our contract with the state of Texas, up to 1% of our Texas health plan’s revenue may be refundable to the state if certain performance measures are not met. These performance measures are generally linked to various quality-of-care measures established by the state. The time period for the assessment of these performance measures previously followed the state’s fiscal year, but effective January 1, 2011, it follows the calendar year. For the six months ended June 30, 2011, our Texas health plan has received $1.2 million in at-risk revenue for calendar year 2011. We have recognized $0.6 million of that amount as revenue, and recorded a liability of approximately $0.6 million as of June 30, 2011, for the remainder. If the state of Texas disagrees with our estimation of our compliance with the at-risk premium requirements, an adjustment to the amounts owed may be required.	

 	•	 	Medicare Premium Revenue: Based on member encounter data that we submit to CMS, our Medicare revenue is subject to retroactive adjustment for both member risk scores and member pharmacy cost experience for up to two years after the original year of service. This adjustment takes into account the acuity of each member’s medical needs relative to what was anticipated when premiums were originally set for that member. In the event that a member requires less acute medical care than was anticipated by the original premium amount, CMS may recover premium from us. In the event that a member requires more acute medical care than was anticipated by the original premium amount, CMS may pay us additional retroactive premium. A similar retroactive reconciliation is undertaken by CMS for our Medicare members’ pharmacy utilization. That analysis is similar to the process for the adjustment of member risk scores, but is further complicated by member pharmacy cost sharing provisions attached to the Medicare pharmacy benefit that do not apply to the services measured by the member risk adjustment process. We estimate the amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members’ heath care utilization patterns and CMS practices. Based on our knowledge of member health care utilization patterns, there is no liability related to the potential recoupment of Medicare premium revenue at June 30, 2011. To the extent that the premium revenue ultimately received from CMS differs from recorded amounts, we will adjust reported Medicare revenue.	
Recognition of Service Revenue and Cost of Service Revenue — Molina Medicaid Solutions Segment
The payments received by our Molina Medicaid Solutions segment under its state contracts are based on the performance of three elements of service. The first of these is the design, development and implementation, or DDI, of a Medicaid Management Information System, or MMIS. The second element, following completion of the DDI element, is the operation of the MMIS under a business process outsourcing, or BPO, arrangement. While providing BPO services, we also provide the state with the third contracted element — training and IT support and hosting services (training and support).
Because they include these three elements of service, our Molina Medicaid Solutions contracts are multiple-element arrangements. The following discussion applies to our contracts with multiple elements entered into prior to January 1, 2011, before our prospective adoption of  ASU No. 2009-13, Revenue Recognition (ASC Topic 605) — Multiple-Deliverable Revenue Arrangements .
For those contracts entered into prior to January 1, 2011, we have no vendor specific objective evidence, or VSOE, of fair value for any of the individual elements in these contracts, and at no point in the contract will we have VSOE for the undelivered elements in the contract. We lack VSOE of the fair value of the individual elements of our Molina Medicaid Solutions contracts for the following reasons:
 	•	 	Each contract calls for the provision of its own specific set of products and services, which vary significantly between contracts; and	

 	•	 	The nature of the MMIS installed varies significantly between our older contracts (proprietary mainframe systems) and our newer contracts (commercial off-the-shelf technology solutions).	
The absence of VSOE within the context of a multiple element arrangement requires us to delay recognition of any revenue for an MMIS contract until completion of the DDI phase of the contract. As a general principle, revenue recognition will therefore commence at the completion of the DDI phase, and all revenue will be recognized over the period that BPO services and training and support services are provided. Consistent with the deferral of revenue, recognition of all direct costs (such as direct labor, hardware, and software) associated with the DDI phase of our contracts is deferred until the commencement of revenue recognition. Deferred costs are recognized on a straight-line basis over the period of revenue recognition.

41

Table of Contents
Provisions specific to each contract may, however, lead us to modify this general principle. In those circumstances, the right of the state to refuse acceptance of services, as well as the related obligation to compensate us, may require us to delay recognition of all or part of our revenue until that contingency (the right of the state to refuse acceptance) has been removed. In those circumstances we defer recognition of any revenue at risk (whether DDI, BPO services, or training and support services) until the contingency has been removed. When we defer revenue recognition we also defer recognition of incremental direct costs (such as direct labor, hardware, and software) associated with the revenue deferred. Such deferred contract costs are recognized on a straight-line basis over the period of revenue recognition.
However, direct costs in excess of the estimated future net revenues associated with a contract may not be deferred. In circumstances where estimated direct costs over the life of a contract exceed estimated future net revenues of that contract, the excess of direct costs over revenue is expensed as a period cost. As noted below, we were unable to defer $7.0 million of direct contract costs associated with our Idaho contract during the second quarter of 2011 because estimated direct costs over the life of the contract exceed estimated future net revenues.
We began to recognize revenue and the related deferred costs associated with our Maine contract in September 2010.
In Idaho, revenue recognition is expected to begin during the second half of 2012. Consistent with the deferral of revenue, we have deferred recognition of the direct contract costs associated with that revenue. Deferred contract costs, if any, deferred through the date revenue recognition begins will be recognized simultaneously with revenue.
In late April of 2011, Idaho Department of Health and Welfare indicated that it wished to remit to us an amount approximately $5 to $6 million less than the amount of our invoices for the operation of the MMIS in that state for the period June 1, 2010 through December 31, 2010. The Department claimed at that time that we were not in compliance with certain contractual requirements during the period June 1, 2010 through December 31, 2010. We do not believe the basis of the proposed reduction was contractually sound. In June 2011, we reached tentative agreement with the Department regarding the determination of our monthly operating revenue in Idaho. As a result of the tentative agreement, we estimate that revenue from operations in Idaho will be reduced by approximately $3 million for the period June 1, 2010 through June 30, 2011, and by an additional $1 million for the period July 1, 2011 through December 31, 2011. We do not believe that the tentative agreement will result in any reduction to amounts previously expected to be received for operations subsequent to December 31, 2011. As noted above, all revenue associated with our Idaho MMIS contract is currently being deferred.
In assessing the recoverability of the deferred contract costs associated with the Idaho contract at June 30, 2011, we determined that our current estimate of expenses over the life of the Idaho MMIS contract exceeded our current estimate of net revenues to be derived from that contract by approximately $7.0 million. Accordingly, we expensed through cost of service revenue $7.0 million of direct costs associated with the Idaho contract that otherwise would have been recorded as deferred contract costs. The reduction in revenue discussed above, as well as higher expected costs over the term of the contract, have lowered the net amount that we expect to realize under the contract, requiring us to write down deferred contract costs. We currently expect the contract to perform financially at a break even basis through its initial term. So long as we continue to defer revenue recognition under the contract, we will also continue to defer direct costs associated with the agreement, unless our analysis indicates that the contract is performing at less than break even.
Molina Medicaid Solutions’ deferred revenue totalled $38.6 million at June 30, 2011, and $10.9 million at December 31, 2010, and unamortized deferred contract costs were $42.6 million at June 30, 2011, and $28.4 million at December 31, 2010.

42

Table of Contents
For all new or materially modified revenue arrangements with multiple elements entered into on or after January 1, 2011, which we expect will consist of contracts entered into by our Molina Medicaid Solutions segment, we apply the guidance contained in ASU No. 2009-13. For these arrangements, we allocate total arrangement consideration to the elements of the arrangement, which are expected to be DDI, BPO, and training and support, because this is consistent with the current elements included in our Molina Medicaid Solutions contracts. The arrangement allocation is performed using the relative selling-price method. When determining the selling price of each element, we first attempt to use VSOE if available. If VSOE is not available, we attempt to use third-party evidence, or TPE, of vendors selling similar services to similarly situated customers on a standalone basis, if available. If neither VSOE nor TPE are available, we use our best estimate of the selling price for each element.
We then evaluate whether, at each stage in the life cycle of the contract, we are able to recognize revenue associated with that element. To the extent that our revenue arrangements have provisions that allow our state customers to refuse acceptance of services performed, we are still required to defer revenue recognition until such state customers accept our performance. Once this acceptance is achieved, we immediately recognize the revenue associated with any delivered elements which differs from our current practice for arrangements entered into prior to January 1, 2011, where the revenue associated with delivered elements is recognized over the final service element of the arrangement because VSOE for the other elements does not exist. As such, we expect that the adoption of ASU No. 2009-13 will result in an overall acceleration of revenue recognition with respect to any multiple-element arrangements entered into on or after January 1, 2011. We have entered into no new or materially modified revenue arrangements with multiple elements since January 1, 2011.
Medical Claims and Benefits Payable — Health Plans Segment
The following table provides the details of our medical claims and benefits payable as of the dates indicated:
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	June 30,	 	 	Dec. 31,	 	 	June 30,	 	
 	 	2011	 	 	2010	 	 	2010	 	
 	 	(In thousands)	 	
Fee-for-service claims incurred but not paid (IBNP)	 	$	270,558	 	 	$	275,259	 	 	$	268,652	 	
Capitation payable	 	 	43,131	 	 	 	49,598	 	 	 	49,101	 	
Pharmacy	 	 	15,094	 	 	 	14,649	 	 	 	13,385	 	
Other	 	 	12,830	 	 	 	14,850	 	 	 	12,662	 	
 	 	 	 	 	 	 	 	 	 	
 	 	$	341,613	 	 	$	354,356	 	 	$	343,800	 	
 	 	 	 	 	 	 	 	 	 	
The determination of our liability for claims and medical benefits payable is particularly important to the determination of our financial position and results of operations in any given period. Such determination of our liability requires the application of a significant degree of judgment by our management.
As a result, the determination of our liability for claims and medical benefits payable is subject to an inherent degree of uncertainty. Our medical care costs include amounts that have been paid by us through the reporting date, as well as estimated liabilities for medical care costs incurred but not paid by us as of the reporting date. Such medical care cost liabilities include, among other items, unpaid fee-for-service claims, capitation payments owed providers, unpaid pharmacy invoices, and various medically related administrative costs that have been incurred but not paid. We use judgment to determine the appropriate assumptions for determining the required estimates.
The most important element in estimating our medical care costs is our estimate for fee-for-service claims which have been incurred but not paid by us. These fee-for-service costs that have been incurred but have not been paid at the reporting date are collectively referred to as medical costs that are “Incurred But Not Paid,” or IBNP. Our IBNP, as reported on our balance sheet, represents our best estimate of the total amount of claims we will ultimately pay with respect to claims that we have incurred as of the balance sheet date. We estimate our IBNP monthly using actuarial methods based on a number of factors. As indicated in the table above, our estimated IBNP liability represented $270.6 million of our total medical claims and benefits payable of $341.6 million as of June 30, 2011. Excluding amounts that we anticipate paying on behalf of a capitated provider in Ohio (which we will subsequently withhold from that provider’s monthly capitation payment), our IBNP liability at June 30, 2011, was $264.1 million.
The factors we consider when estimating our IBNP include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, health care service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza, provider contract changes, changes to Medicaid fee schedules, and the incidence of high dollar or catastrophic claims. Our assessment of these factors is then translated into an estimate of our IBNP liability at the relevant measuring point through the calculation of a base estimate of IBNP, a further reserve for adverse claims development, and an estimate of the administrative costs of settling all claims incurred through the reporting date. The base estimate of IBNP is derived through application of claims payment completion factors and trended PMPM cost estimates.

43

Table of Contents
For the fifth month of service prior to the reporting date and earlier, we estimate our outstanding claims liability based on actual claims paid, adjusted for estimated completion factors. Completion factors seek to measure the cumulative percentage of claims expense that will have been paid for a given month of service as of the reporting date, based on historical payment patterns.
The following table reflects the change in our estimate of claims liability as of June 30, 2011 that would have resulted had we changed our completion factors for the fifth through the twelfth months preceding June 30, 2011, by the percentages indicated. A reduction in the completion factor results in an increase in medical claims liabilities. Dollar amounts are in thousands.
 	 	 	 	 	
 	 	Increase (Decrease) in	 	
 	 	Medical Claims and	 	
(Decrease) Increase in Estimated Completion Factors	 	Benefits Payable	 	
(6%)	 	$	106,455	 	
(4%)	 	 	70,970	 	
(2%)	 	 	35,485	 	
2%	 	 	(35,485	)	
4%	 	 	(70,970	)	
6%	 	 	(106,455	)	
For the four months of service immediately prior to the reporting date, actual claims paid are not a reliable measure of our ultimate liability, given the inherent delay between the patient/physician encounter and the actual submission of a claim for payment. For these months of service, we estimate our claims liability based on trended PMPM cost estimates. These estimates are designed to reflect recent trends in payments and expense, utilization patterns, authorized services, and other relevant factors. The following table reflects the change in our estimate of claims liability as of June 30, 2011 that would have resulted had we altered our trend factors by the percentages indicated. An increase in the PMPM costs results in an increase in medical claims liabilities. Dollar amounts are in thousands.
 	 	 	 	 	
 	 	Increase (Decrease) in	 	
 	 	Medical Claims and	 	
(Decrease) Increase in Trended Per member Per Month Cost Estimates	 	Benefits Payable	 	
(6%)	 	$	(60,630	)	
(4%)	 	 	(40,420	)	
(2%)	 	 	(20,210	)	
2%	 	 	20,210	 	
4%	 	 	40,420	 	
6%	 	 	60,630	 	
The following per-share amounts are based on a combined federal and state statutory tax rate of 37.5%, and 46.4 million diluted shares outstanding for the six months ended June 30, 2011. Assuming a hypothetical 1% change in completion factors from those used in our calculation of IBNP at June 30, 2011, net income for the six months ended June 30, 2011 would increase or decrease by approximately $11.1 million, or $0.24 per diluted share. Assuming a hypothetical 1% change in PMPM cost estimates from those used in our calculation of IBNP at June 30, 2011, net income for the three months ended June 30, 2011 would increase or decrease by approximately $6.3 million, or $0.14 per diluted share. The corresponding figures for a 5% change in completion factors and PMPM cost estimates would be $55.4 million, or $1.20 per diluted share, and $31.6 million, or $0.68 per diluted share, respectively.

44

Table of Contents
It is important to note that any change in the estimate of either completion factors or trended PMPM costs would usually be accompanied by a change in the estimate of the other component, and that a change in one component would almost always compound rather than offset the resulting distortion to net income. When completion factors are overestimated , trended PMPM costs tend to be  underestimated . Both circumstances will create an overstatement of net income. Likewise, when completion factors are  underestimated , trended PMPM costs tend to be  overestimated , creating an understatement of net income. In other words, errors in estimates involving both completion factors and trended PMPM costs will usually act to drive estimates of claims liabilities and medical care costs in the same direction. If completion factors were overestimated by 1%, resulting in an overstatement of net income by approximately $11.1 million, it is likely that trended PMPM costs would be underestimated, resulting in an additional overstatement of net income.
After we have established our base IBNP reserve through the application of completion factors and trended PMPM cost estimates, we then compute an additional liability, once again using actuarial techniques, to account for adverse developments in our claims payments which the base actuarial model is not intended to and does not account for. We refer to this additional liability as the provision for adverse claims development. The provision for adverse claims development is a component of our overall determination of the adequacy of our IBNP. It is intended to capture the potential inadequacy of our IBNP estimate as a result of our inability to adequately assess the impact of factors such as changes in the speed of claims receipt and payment, the relative magnitude or severity of claims, known outbreaks of disease such as influenza, our entry into new geographical markets, our provision of services to new populations such as the aged, blind or disabled (ABD), changes to state-controlled fee schedules upon which a large proportion of our provider payments are based, modifications and upgrades to our claims processing systems and practices, and increasing medical costs. Because of the complexity of our business, the number of states in which we operate, and the need to account for different health care benefit packages among those states, we make an overall assessment of IBNP after considering the base actuarial model reserves and the provision for adverse claims development. We also include in our IBNP liability an estimate of the administrative costs of settling all claims incurred through the reporting date. The development of IBNP is a continuous process that we monitor and refine on a monthly basis as additional claims payment information becomes available. As additional information becomes known to us, we adjust our actuarial model accordingly to establish IBNP.
On a monthly basis, we review and update our estimated IBNP and the methods used to determine that liability. Any adjustments, if appropriate, are reflected in the period known. While we believe our current estimates are adequate, we have in the past been required to increase significantly our claims reserves for periods previously reported, and may be required to do so again in the future. Any significant increases to prior period claims reserves would materially decrease reported earnings for the period in which the adjustment is made.
In our judgment, the estimates for completion factors will likely prove to be more accurate than trended PMPM cost estimates because estimated completion factors are subject to fewer variables in their determination. Specifically, completion factors are developed over long periods of time, and are most likely to be affected by changes in claims receipt and payment experience and by provider billing practices. Trended PMPM cost estimates, while affected by the same factors, will also be influenced by health care service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, outbreaks of disease or increased incidence of illness, provider contract changes, changes to Medicaid fee schedules, and the incidence of high dollar or catastrophic claims. As discussed above, however, errors in estimates involving trended PMPM costs will almost always be accompanied by errors in estimates involving completion factors, and vice versa. In such circumstances, errors in estimation involving both completion factors and trended PMPM costs will act to drive estimates of claims liabilities (and therefore medical care costs) in the same direction.
Assuming that base reserves have been adequately set, we believe that amounts ultimately paid out should generally be between 8% and 10% less than the liability recorded at the end of the period as a result of the inclusion in that liability of the allowance for adverse claims development and the accrued cost of settling those claims. However, there can be no assurance that amounts ultimately paid out will not be higher or lower than this 8% to 10% range, as shown by our results for the year ended December 31, 2010, when the amounts ultimately paid out were less than the amount of the reserves we had established as of the beginning of that year by 15.7%.
As shown in greater detail in the table below, the amounts ultimately paid out on our liabilities in fiscal years 2010 and through June 30, 2011 were less than what we had expected when we had established our reserves. While the specific reasons for the overestimation of our liabilities were different in each of the periods presented, in general the overestimations were tied to our assessment of specific circumstances at our individual health plans which were unique to those reporting periods.

45

Table of Contents
We recognized a benefit from prior period claims development in the amount of $45.4 million for the six months ended June 30, 2011 (see table below). This amount represents our estimate as of June 30, 2011 of the extent to which our initial estimate of medical claims and benefits payable at December 31, 2010 exceeded the amount that will ultimately be paid out in satisfaction of that liability. The overestimation of claims liability at December 31, 2010 was due primarily to the following factors:
 	•	 	We overestimated the impact of an increase in pending high dollar claims at our Ohio health plan.	

 	•	 	We underestimated the lower cost associated with changes to provider fee schedules (primarily for outpatient facility costs) in New Mexico effective November 1, 2010.	
The following developments partially offset the overestimation of our claims liability at December 31, 2010:
 	•	 	In Missouri, delays in claims processing late in the fourth quarter of 2010 led us to underestimate the size of our claims liability at December 31, 2010.	

 	•	 	We underestimated the costs associated with our assumption of risk for a new population in Texas (rural CHIP members) effective September 1, 2010.	
We recognized a benefit from prior period claims development in the amount of $49.4 million for the year ended December 31, 2010 (see table below). This was primarily caused by the overestimation of our liability for claims and medical benefits payable at December 31, 2009. The overestimation of claims liability at December 31, 2009 was the result of the following factors:
 	•	 	In New Mexico, we underestimated the degree to which cuts to the Medicaid fees schedule would reduce our liability as of December 31, 2009.	

 	•	 	In California, we underestimated the extent to which various network restructuring, provider contracting, and medical management initiatives had reduced our medical care costs during the second half of 2009, thereby resulting in a lower liability at December 31, 2009.	
In estimating our claims liability at June 30, 2011, we adjusted our base calculation to take account of the following factors which we believe are reasonably likely to change our final claims liability amount:
 	•	 	The assumption of risk for a new population by our Texas health plan (Dallas-Fort Worth area ABD members) effective February 1, 2011.	

 	•	 	The transition of certain members by our Washington and Michigan health plans from full-risk capitated provider arrangements to fee-for-service providers effective December 31, 2010. This change had the effect of transferring back to the Company risk that had previously been assumed by capitated medical providers.	

 	•	 	A substantial decline in claims inventory at our Michigan, Missouri, and Texas health plans.	
The use of a consistent methodology in estimating our liability for claims and medical benefits payable minimizes the degree to which the under- or overestimation of that liability at the close of one period may affect consolidated results of operations in subsequent periods. Facts and circumstances unique to the estimation process at any single date, however, may still lead to a material impact on consolidated results of operations in subsequent periods. Any absence of adverse claims development (as well as the expensing through general and administrative expense of the costs to settle claims held at the start of the period) will lead to the recognition of a benefit from prior period claims development in the period subsequent to the date of the original estimate. In 2010 and through June 30, 2011, the absence of adverse development of the liability for claims and medical benefits payable at the close of the previous period resulted in the recognition of substantial favorable prior period development. In both years, however, the recognition of a benefit from prior period claims development did not have a material impact on our consolidated results of operations because the amount of benefit recognized in each year was roughly consistent with that recognized in the previous year.

46

Table of Contents
The following table presents the components of the change in our medical claims and benefits payable for the periods presented. The negative amounts displayed for “ Components of medical care costs related to:  Prior periods” represent the amount by which our original estimate of claims and benefits payable at the beginning of the period exceeded the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported.
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	Three	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	Months	 	 	Year	 	
 	 	Six Months Ended	 	 	Ended	 	 	Ended	 	
 	 	June 30,	 	 	June 30,	 	 	March 31,	 	 	December 31,	 	
 	 	2011	 	 	2010	 	 	2011	 	 	2010	 	
 	 	(Dollars in thousands, except	 	
 	 	per-member amounts)	 	
Balances at beginning of period	 	$	354,356	 	 	$	315,316	 	 	$	354,356	 	 	$	315,316	 	
Balance of acquired subsidiary	 	 	—	 	 	 	—	 	 	 	—	 	 	 	3,228	 	
Components of medical care costs related to:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Current period	 	 	1,908,289	 	 	 	1,705,411	 	 	 	957,909	 	 	 	3,420,235	 	
Prior periods	 	 	(45,398	)	 	 	(42,982	)	 	 	(44,377	)	 	 	(49,378	)	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total medical care costs	 	 	1,862,891	 	 	 	1,662,429	 	 	 	913,532	 	 	 	3,370,857	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Payments for medical care costs related to:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Current period	 	 	1,584,636	 	 	 	1,389,907	 	 	 	646,428	 	 	 	3,085,388	 	
Prior periods	 	 	290,998	 	 	 	244,038	 	 	 	270,078	 	 	 	249,657	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Total paid	 	 	1,875,634	 	 	 	1,633,945	 	 	 	916,506	 	 	 	3,335,045	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Balances at end of period	 	$	341,613	 	 	$	343,800	 	 	$	351,382	 	 	$	354,356	 	

Benefit from prior period as a percentage of:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at beginning of period	 	 	12.8	%	 	 	13.6	%	 	 	12.5	%	 	 	15.7	%	
Premium revenue	 	 	2.1	%	 	 	2.2	%	 	 	4.1	%	 	 	1.2	%	
Total medical care costs	 	 	2.4	%	 	 	2.6	%	 	 	4.9	%	 	 	1.5	%	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Claims Data:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Days in claims payable, fee for service	 	 	39	 	 	 	44	 	 	 	41	 	 	 	42	 	
Number of members at end of period	 	 	1,645,000	 	 	 	1,498,000	 	 	 	1,647,000	 	 	 	1,613,000	 	
Number of claims in inventory at end of period	 	 	121,900	 	 	 	106,700	 	 	 	185,300	 	 	 	143,600	 	
Billed charges of claims in inventory at end of period	 	$	205,800	 	 	$	147,500	 	 	$	250,600	 	 	$	218,900	 	
Claims in inventory per member at end of period	 	 	0.07	 	 	 	0.07	 	 	 	0.11	 	 	 	0.09	 	
Billed charges of claims in inventory per member at end of period	 	$	125.11	 	 	$	98.46	 	 	$	152.16	 	 	$	135.71	 	
Number of claims received during the period	 	 	8,715,200	 	 	 	7,066,100	 	 	 	4,342,200	 	 	 	14,554,800	 	
Billed charges of claims received during the period	 	$	6,963,300	 	 	$	5,605,400	 	 	$	3,386,600	 	 	$	11,686,100	 	
Inflation
We use various strategies to mitigate the negative effects of health care cost inflation. Specifically, our health plans try to control medical and hospital costs through contracts with independent providers of health care services. Through these contracted providers, our health plans emphasize preventive health care and appropriate use of specialty and hospital services. There can be no assurance, however, that our strategies to mitigate health care cost inflation will be successful. Competitive pressures, new health care and pharmaceutical product introductions, demands from health care providers and customers, applicable regulations, or other factors may affect our ability to control health care costs.
Compliance Costs
Our health plans are regulated by both state and federal government agencies. Regulation of managed care products and health care services is an evolving area of law that varies from jurisdiction to jurisdiction. Regulatory agencies generally have discretion to issue regulations and interpret and enforce laws and rules. Changes in applicable laws and rules occur frequently. Compliance with such laws and rules may lead to additional costs related to the implementation of additional systems, procedures and programs that we have not yet identified.

47

Table of Contents
 	 	 	
Item 3.	 	Quantitative and Qualitative Disclosures About Market Risk.	
Concentrations of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. We invest a substantial portion of our cash in the PFM Fund Prime Series — Institutional Class, and the PFM Fund Government Series. These funds represent a portfolio of highly liquid money market securities that are managed by PFM Asset Management LLC (PFM), a Virginia business trust registered as an open-end management investment fund. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. No investment that is in a loss position can be sold by our managers without our prior approval. Our investments consist solely of investment grade debt securities with a maximum maturity of five years and an average duration of two years or less. Restricted investments are invested principally in certificates of deposit and U.S. treasury securities. Concentration of credit risk with respect to accounts receivable is limited due to payors consisting principally of the governments of each state in which our Health Plans segment and our Molina Medicaid Solutions segment operate.
 	 	 	
Item 4.	 	Controls and Procedures	
Evaluation of Disclosure Controls and Procedures: Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has concluded, based upon its evaluation as of the end of the period covered by this report, that the Company’s  “disclosure controls and procedures”  (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the  “Exchange Act” )) are effective to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.
Changes in Internal Control Over Financial Reporting: During the fiscal quarter ended June 30, 2011, we completed the implementation of a new enterprise resource planning, or ERP, software system. This system is used in the preparation of, among other things, our financial statements and required reports. Other than the ERP implementation, there has been no change in our internal control over financial reporting during the fiscal quarter ended June 30, 2011 that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

48

Table of Contents
PART II — OTHER INFORMATION
 	 	 	
Item 1.	 	Legal Proceedings	
The health care industry is subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines, exclusion from participating in publicly-funded programs, and the repayment of previously billed and collected revenues.
We are involved in various legal actions in the normal course of business, some of which seek monetary damages, including claims for punitive damages, which are not covered by insurance. Based upon the evaluation of information currently available, we believe that these actions, when finally concluded and determined, are not likely to have a material adverse effect on our business, financial condition, cash flows, or results of operations.
 	 	 	
Item 1A.	 	Risk Factors	
Certain risk factors may have a material adverse effect on our business, financial condition, cash flows, or results of operations, and you should carefully consider them. The following risk factor was identified by the Company during the second quarter of 2011 and is a supplement to the risk factors identified in Part I, Item 1A — Risk Factors, in our Annual Report on Form 10-K for the year ended December 31, 2010 as filed with the SEC on March 8, 2011. The risk factor described herein and in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition, cash flows, or results of operations.
An impairment charge with respect to our recorded goodwill or indefinite-lived intangible assets could have a material impact on our financial results.
We conduct formal impairment tests on material long-lived assets, such as goodwill and indefinite-lived intangible assets, and intangible assets, net, at least annually; additionally, we continually evaluate whether events or changes in business conditions suggest potential impairment of such assets. Our judgments regarding the existence of impairment indicators are based on legal factors, market conditions, and operational performance. For example, our health plan subsidiaries have generally been successful in obtaining the renewal by amendment of their contracts in each state prior to the actual expiration of their contracts. However, there can be no assurance that these contracts will continue to be renewed. The non-renewal of such a contract would be an indicator of impairment.
As of June 30, 2011, the balance of goodwill and indefinite-lived intangible assets was $212.5 million. Goodwill and indefinite-lived assets are not amortized, but are subject to impairment tests on an annual basis or more frequently if indicators of impairment exist. As of June 30, 2011, the balance of intangible assets, net, was $91.2 million. Intangible assets are amortized generally on a straight-line basis over their estimated useful lives. The determination of the value of goodwill and indefinite-lived intangible assets, and intangible assets, net, requires us to make estimates and assumptions about estimated asset lives, future business trends, and growth. Such evaluation is significantly impacted by estimates and assumptions of future revenues, costs and expenses, and other factors.
If an event or events occur that would cause us to revise our estimates and assumptions used in analyzing the value of our goodwill and indefinite-lived intangible assets, and intangible assets, net, such revision could result in a non-cash impairment charge that could have a material impact on our financial results.
 	 	 	
Item 6.	 	Exhibits	

Exhibit No.	 	Title	
 	31.1	 	 	Certification of Chief Executive Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.	
 	 	 	 	 	
 	31.2	 	 	Certification of Chief Financial Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.	
 	 	 	 	 	
 	32.1	 	 	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	
 	 	 	 	 	
 	32.2	 	 	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	
 	 	 	 	 	
101.INS(	1)	 	XBRL Taxonomy Instance Document.	
 	 	 	 	 	
101.SCH	(1)	 	XBRL Taxonomy Extension Schema Document.	
 	 	 	 	 	
101.CAL	(1)	 	XBRL Taxonomy Extension Calculation Linkbase Document.	
 	 	 	 	 	
101.DEF	(1)	 	XBRL Taxonomy Extension Definition Linkbase Document.	
 	 	 	 	 	
101.LAB	(1)	 	XBRL Taxonomy Extension Label Linkbase Document.	
 	 	 	 	 	
101.PRE	(1)	 	XBRL Taxonomy Extension Presentation Linkbase Document.	

(1)	 	XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.	

49

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 	 	 	 	 	
 	MOLINA HEALTHCARE, INC.
(Registrant)
 	 	
Dated: July 27, 2011 	/s/ JOSEPH M. MOLINA, M.D.  	 	
 	Joseph M. Molina, M.D. 	 	
 	Chairman of the Board,
Chief Executive Officer and President
(Principal Executive Officer)  	 	
 	 	 	
Dated: July 27, 2011 	/s/ JOHN C. MOLINA, J.D.  	 	
 	John C. Molina, J.D. 	 	
 	Chief Financial Officer and Treasurer
(Principal Financial Officer)  	 	

50

Table of Contents
EXHIBIT INDEX
 	 	 	 	 	
Exhibit No.	 	Title	
 	31.1	 	 	Certification of Chief Executive Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.	
 	 	 	 	 	
 	31.2	 	 	Certification of Chief Financial Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.	
 	 	 	 	 	
 	32.1	 	 	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	
 	 	 	 	 	
 	32.2	 	 	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	
 	 	 	 	 	
101.INS(	1)	 	XBRL Taxonomy Instance Document.	
 	 	 	 	 	
101.SCH	(1)	 	XBRL Taxonomy Extension Schema Document.	
 	 	 	 	 	
101.CAL	(1)	 	XBRL Taxonomy Extension Calculation Linkbase Document.	
 	 	 	 	 	
101.DEF	(1)	 	XBRL Taxonomy Extension Definition Linkbase Document.	
 	 	 	 	 	
101.LAB	(1)	 	XBRL Taxonomy Extension Label Linkbase Document.	
 	 	 	 	 	
101.PRE	(1)	 	XBRL Taxonomy Extension Presentation Linkbase Document.	

(1)	 	XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.	

51

EXHIBIT 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a)/15d-14(a)
UNDER THE SECURITIES EXCHANGE
ACT OF 1934, AS AMENDED
I, Joseph M. Molina, M.D., certify that:
1. I have reviewed the report on Form 10-Q for the period ended June 30, 2011 of Molina Healthcare, Inc.;
2. Based on my knowledge, the report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
3. Based on my knowledge, the financial statements, and other financial information included in the report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in the report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended), and internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended), for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period for which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in the report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by the report based on such evaluation; and
(d) Disclosed in the report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and to the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 	 	 	 	 	
Dated: July 27, 2011 	/s/ Joseph M. Molina, M.D.  	 	
 	Joseph M. Molina, M.D. 	 	
 	Chairman of the Board,
Chief Executive Officer and President  	 	

 

EXHIBIT 31.2
CERTIFICATION PURSUANT TO
RULES 13a-14(a)/15d-14(a)
UNDER THE SECURITIES EXCHANGE
ACT OF 1934, AS AMENDED
I, John C. Molina, J.D., certify that:
1. I have reviewed the report on Form 10-Q for the period ended June 30, 2011 of Molina Healthcare, Inc.;
2. Based on my knowledge, the report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
3. Based on my knowledge, the financial statements, and other financial information included in the report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in the report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended), and internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended), for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period for which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in the report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by the report based on such evaluation; and
(d) Disclosed in the report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and to the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 	 	 	 	 	
Dated: July 27, 2011 	/s/ John C. Molina, J.D.  	 	
 	John C. Molina, J.D. 	 	
 	Chief Financial Officer and Treasurer 	 	

 

EXHIBIT 32.1
CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the report of Molina Healthcare, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2011 (the “Report”), I, Joseph M. Molina, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 	 	 	 	 	
Dated: July 27, 2011 	/s/ Joseph M. Molina, M.D.  	 	
 	Joseph M. Molina, M.D. 	 	
 	Chairman of the Board,
Chief Executive Officer and President  	 	

 

EXHIBIT 32.2
CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the report of Molina Healthcare, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2011 (the “Report”), I, John C. Molina, J.D., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 	 	 	 	 	
Dated: July 27, 2011 	/s/ John C. Molina, J.D.  	 	
 	John C. Molina, J.D. 	 	
 	Chief Financial Officer and Treasurer